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NEUROCHEMICAL FACTORS ASSOCIATED WITH THE INITIAL 
PATHOPHYSIOLOGICAL REACTION TO LARGE VESSEL OCCLUSION STROKE 
 
Ischemic stroke is the leading cause of disability world-wide and affects over 
800,000 people per year in the United States. The majority of these strokes are ischemic 
due to a blockage of blood flow to the brain. Damage to the brain occurs at the onset of 
stroke, neuronal cell death is irreversible and therefore, quick treatment to remove 
blockage is critical factor in the recovery from stroke. Mechanical thrombectomy as a 
treatment for ischemic stroke provides an ideal opportunity to collect blood distal and 
proximal to the cerebral thrombus to examine neurochemical changes occurring during 
stroke. 
The purpose of this dissertation was to explore the trajectory of neurochemical 
changes that occur in response to ischemic stroke during the first 72 hours and the 
physiological response from stroke patients to improve stroke outcomes. The specific 
aims were to: 1) to determine whether venous blood gases predict infarct volume and/or 
mortality in acute ischemic stroke in young male rats; 2) determine whether venous blood 
gases predict infarct and edema volume, and/or mortality in acute ischemic stroke in aged 
male and female rats; 3) compare the presence and relative concentrations of acid/base 
and electrolytes in static blood distal to thrombus and in peripheral blood drawn from 
adults who received thrombectomy for ischemic stroke and identify associations to post-
reperfusion functional outcomes.  
Specific Aim One was addressed by evaluation of young (three-month old) 
Sprague-Dawley rats that underwent permanent or transient middle cerebral artery 
occlusion (MCAO). Pre- and post-MCAO venous samples from permanent and transient 
models provided pH, carbon dioxide, oxygen, bicarbonate, glucose, hematocrit, 
hematocrit, and electrolyte values of ionized calcium, potassium and sodium. The 
analyses indicated that mean differences in the blood gas and electrolytes between pre- to 
post-MCAO and pH and iCa2+ were predictors of infarct volume in the permanent 
MCAO model. The second aim was addressed by evaluation of aged (18 month old) male 
and female rats pre-MCAO, post-MCAO, and at 72 hours of permanent MCAO venous 
     
 
blood gas samples (pH, carbon dioxide, oxygen, bicarbonate, glucose, hematocrit, 
hematocrit, and electrolyte concentrations of ionized calcium, potassium and sodium). 
Changes in pH (from pre-MCAO to post-MACO and post-MCAO to 72 hours) and 
changes in Na+ and iCa2+ (from post-MCAO to 72 hours) were predictors of infarct 
volume and edema volume, respectively in both sexes. Cox regression revealed there was 
a 3.25 times increased risk for mortality based on changes (cut-off range within -2.00 to -
7.00) in bicarbonate levels (pre- to post-MCAO). The third aim was addressed by 
evaluation of acid/base balance (pH, carbon dioxide, oxygen, bicarbonate, ionized 
calcium, potassium and sodium) of ischemic stroke patients who underwent mechanical 
thrombectomy. Our results suggests sex differences matter in ischemic stroke 
populations. Significant differences occur within proximal blood between the sexes. 
Additionally, females had approximately 2.5 hour increased time between stroke 
symptom onset to thrombectomy completion time (described as infarct time). Changes in 
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CHAPTER 1. INTRODUCTION 
Background 
Ischemic stroke is the leading cause of disability in the United States and affects 
over 800,000 Americans per year [1]. It is the third leading cause of death for women, 
occuring in about 55,000 more women than men each year [1]. African Americans have 
twice the risk of having a first stroke when compared with Caucasians, in addition to an 
increased mortality rate from stroke [1]. In Kentucky, stroke is the fifth leading cause of 
mortality [2]. Given the pervasiveness of stroke, it is critical to develop a more complete 
understanding of the pathophysiology at the time of stroke onset; these insights may 
reveal potential targets for stroke treatment. 
The majority of strokes (87%) are ischemic and result from a thrombus 
obstructing a major artery in the brain [1]. The blockage caused by the thrombus 
produces initial hypoxic damage that is followed by ischemia and inflammation [3, 4]. As 
neurons die, they produce an infarct core. The penumbra, the area surrounding the infarct, 
also includes neurons and tissue at risk of cell death, and will expand to adjacent neurons 
if reperfusion does not occur [5]. Shifts occur within the cerebral blood flow (CBF) 
leading to disturbances in brain metabolism. Water, ionic concentrations, and other 
biochemical properties begin to change due to the obstruction and the decreasing CBF. 
Disruption in blood flow reduces oxygen (O2) and glucose, and leads adenosine 
triphosphate (ATP) to be mismatched with use and production [6]. Oxygen availability to 
the brain is the product of CBF and the O2 content of arterial blood. Cerebral ischemia 
occurs when metabolic demand for O2 is not met.  
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The presence of the thrombus decreases CBF resulting acidosis due to a lack of 
glucose and an increase in carbon dioxide (CO2). A lack of glucose triggers cellular 
glycolysis increasing of lactic acid production and a lowering in pH disrupting normal 
acid/base balance within the brain [7, 8]. During ischemia, CO2 from neural cells 
accumulate in intracellular spaces, which lead to a further reduction in pH levels [9].  
When blood pH decreases, electrolyte concentrations of sodium (Na+), calcium 
(Ca2+) and potassium (K+) which maintain cellular structure and function are affected [6]. 
Dysregulation of ion gradients within neuronal cell membrane transport system occurs in 
Na+/K+ and Na+/Ca2+ pumps. Under normal conditions Na+ is pumped out of the cell and 
K+ into the cell, but without a supply of ATP, the pump stops working properly. The 
increased concentration of intracellular Na+ leads to cytogenic edema. The disruption of 
the Na+/Ca2+ pump leads to an increased concentration of intracellular Ca2+, which is 
detrimental in several ways [10]. It causes excitotoxicity by the release of glutamate 
neurotransmitters, which spurs neighboring neurons to also become overexcited. It also 
activates lipases that break down neuron cell membranes allowing other ions to enter the 
neuron. Finally, this process produces an increase of cytoplasmic calcium causing 
mitochondrial dysfunction, leading to the generation of free radicals and reactive oxygen 
species (ROS) that are responsible for neural cell death [10]. 
These initial pathophysiological changes can produce irreversible neuronal cell 
death and therefore, time is critical in the treatment of stroke. Current treatments break up 
or remove the thrombus using tissue plasminogen activator (tPA) and/or mechanical 
thrombectomy [11-13]. tPA catalyzes the conversion of plasminogen to plasmin and is 
the primary mechanism for thrombolysis. The use of intravascular tPA is time dependent 
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and patients can only be administered tPA within 4.5 hours after stroke onset. Mechanical 
thrombectomy is an intraarterial procedure to remove a thrombus and re-establish blood 
flow for emergent large vessel occlusions (ELVO) [14, 15]. Recently, the American 
Heart Association/American Stroke Association changed the time window for 
mechanical thrombectomy; the recommendation moved from a 6-hour treatment window 
to 24 hours [16-18]. 
Interestingly, thombectomy has also provided researchers with a rare opportunity 
to examine neurochemical changes that occur during stroke. It allows researchers to 
isolate blood within the artery immediately distal and proximal to the thrombus (systemic 
arterial blood in the cervical carotid artery) [19]. The analysis of these blood samples 
may help us better understand early neurochemical changes after stroke onset to assist in 
the development of adjunctive therapies to compliment current stroke treatments. 
Acid/Base Balance and Electrolyte Concentration in Large Vessel Occlusion 
Researchers have examined the relationship of venous and arterial blood gas 
parameters in critically ill patients [20-25] and in rodent models [26, 27]. These studies 
demonstrate that venous blood gas values in rodents and humans are similar and therefore 
comparable. Flores et al. (2011) examined arterial blood gases and electrolyte 
concentrations in distal blood adjacent to the cerebral thrombus and peripheral blood 
from the carotid artery during mechanical thrombectomy of ischemic stroke patients (n = 
16), with results indicating significant differences between the two blood samples in 
partial pressure oxygen (distal 73.9 ± 14.9 and proximal 78.9 ± 16.3, p = 0.007) and 
oxygen saturation (distal 93.2 ± 4.4 and proximal 94.3 ± 3.9, p = 0.003) [28]. Back et al. 
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(2000) assessed pH regulation in rodents within 30 minutes and six hours of permanent 
middle cerebral artery occlussion (MCAO) model. They found acidosis (pH = 6.03) in 
the infarct core and alkalosis (pH = 7.32) in the penumbral area [8]. Together, these 
studies provide initial insights into acid/base balance and electrolyte concentrations. The 
gap in the knowledge is that we do not have blood gas values at baseline or stroke onset 
in large vessel occlusion and how these contribute to subsequent physiological changes 
like infarct and edema volumes and eventually outcomes. This study uses larger sample 
sizes of both rodent models and individuals diagnosed with ischemic stroke to examine 
associations of blood gases and electolyte concentrations to infarct and edema volumes, 
mortality, and infarct time. 
Researchers have also examined electrolyte changes that occur during stroke. A 
lowering in total serum calcium concentrations in peripheral venous blood in stroke 
patients were associated with more severe clinical symptoms following stroke onset, 
including worse functional outcomes and an ishemic stroke to hemorrhagic conversion 
after thrombectomy [29-31]. Higher total serum calcium levels from peripheral venous 
blood were detected on patient admission or within 24 hours of stroke onset were 
associated with improved functional outcomes and decreased infarct volumes [32-34]. 
Serum Na+ levels from peripheral venous samples were associated with stroke severity 
but the results are inconclusive. Rodrigues et al. [35] and Soiza et al. [36] found patients’ 
with lower sodium levels or hyponatremia were associated with increased stroke severity 
and risk for mortality. Others have observed higher venous serum sodium concentrations 
were associated with stroke incidence and neurological worsening [37-39]. Serum Na+ 
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levels in the healthy group of controls were lower than in patients with transient ischemic 
attack and with ischemic and hemorrhagic strokes [40]. 
Purpose and Overview of Dissertation 
The purpose of this dissertation was to explore the trajectory of neurochemical 
changes that occur in response to large vessel occlusion during the first 72 hours in 
rodent models and from ischemic stroke patients to improve stroke outcomes. The aims 
of dissertation were to: 1) to determine whether venous blood gases predicted infarct 
volume and/or mortality in acute ischemic stroke in young male rats; 2) determine 
whether venous blood gases predicted infarct volume, edema volume, and/or mortality in 
acute ischemic stroke in aged male and female rats; 3) compare acid/base balance and 
electrolytes in static blood distal to thrombus and in peripheral circulation drawn from 
adults who received thrombectomy for ischemic stroke and identify associations to post-
reperfusion outcomes (infarct and edema volumes, and infarct time), after controlling for 
gender, BMI, and admission National Institutes of Health Stroke Scale NIHSS. 
To date, no other study has examined acid/base balance and electrolyte changes 
this early after occlusion in permanent and transient-MCAO rat models or examined 
these changes in aged male and female rats. In addition, this is the first time these 
changes were tested as predictors of infarct volume, edema volume, and/or mortality in 
rats. We also evaluated blood gas and electrolyte values in the distal and peripheral blood 
adjacent to the cerebral thrombus at early time points after stroke in humans. These 
findings will aid in reverse translation from human to rodent models, so stroke models 
can focus on the most appropriate clinical endpoints and patient population. The results 
of this dissertation will increase our knowledge of stroke pathology and assist in 
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optimizing translational research seen in both rodent models and in humans. This work 
has the potential to fundamentally change how we develop treatment strategies for the 
stroke patient population. 
Chapter Overviews 
Chapter Two is a descriptive correlational design assessing acid/base balance (pH, 
carbon dioxide, oxygen, bicarbonate, base excess, glucose, hematocrit, and hemoglobin) 
and electrolyte concentrations (ionized calcium, potassium and sodium) changes that 
occur within a few minutes of focal ischemia in permanent middle cerebral artery 
occlusion (MCAO) and transient MCAO stroke models in young (three-month-old) male 
rats. The gap in the knowledge is that we do not have literature comparing acid/base and 
electrolyte concentrations in two focal ischemia models. These animal models mirror two 
stroke situations – a patient receiving stroke treatments and the natural history of a stroke 
patient. Additionally, there is no existing literature that evaluates early acid/base and 
electrolytes in focal ischemia and uses these values for predictors of stroke outcomes 
(infarct volume and/or mortality). Data from these models were analyzed using paired 
samples t-tests, Kaplan-Meier survival curve, and multiple linear regression analyses. 
This chapter is a published manuscript, Translational Evaluation of Acid/Base and 
Electrolyte Alterations in Rodent Model of Focal Ischemia, in Journal of Stroke and 
Cerebrovascular Diseases (JSCVD) (published 08/03/2018) [41]. 
Chapter Three reports a descriptive correlational study of acid/base balance and 
electrolyte changes occurring within a few minutes of focal ischemia and occlusion in the 
permanent middle cerebral artery occlusion (MCAO) model in aged (18-month-old) male 
and female rats. The blood gases were collected 1) pre-MCAO, 2) post-MCAO 
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(approximately seven minutes) and at 3) 72 hours post-MRI and prior to euthanization. 
The gap in the knowledge is that most stroke studies use young male rats as their 
population, and this does not reflect the age or sex balance of the patient population that 
suffers from strokes. This study included aged male and female rats to evaluate early 
acid/base and electrolyte values, as well as to determine predictors of infarct volume, 
edema volume, and mortality in older animals. Additionally, we compared our results to 
those reported in Chapter Two, and assessed the sex differences in our aged animals.  
Data from these models were analyzed using a one-way repeated measures ANOVA, 
multiple linear regression, and Cox regression analyses. This chapter is a published 
manuscript, Early Acid/Base and Electrolyte Changes in Permanent Middle Cerebral 
Artery Occlusion: Aged Male and Female Rats, in the Journal of Neuroscience Research 
(JNR) on 4/4/2019 [42]. 
Chapter Four reports a descriptive correlational design study of acid/base and 
electrolyte concentrations in distal and proximal arterial blood (relative to the thrombi) 
from ischemic stroke participants at the time of mechanical thrombectomy. The gap in 
the knowledge is that there is little evidence of arterial blood gases at the time of 
ischemic stroke and during mechanical thrombectomy, especially related to sex 
differences. This study compares acid/base balance and electrolyte concentrations 
between male and female ischemic stroke participants. Additionally, we were interested 
in predictors of stroke outcomes and infarct time, and whether these were sex dependent. 
The data for this study were analyzed using a one-way repeated measures ANOVA and 
moderated multiple linear regression. This manuscript, Evaluation of Sex Differences in 
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Acid/Base and Electrolyte Alterations in Acute Large Vessel Occlusion is in preparation 
for the submission to Journal of Neurointerventional Surgery (JNIS). 
Chapter Five is a discussion of how each manuscript contributes to the state of the 
science on large vessel occlusion stroke. In addition, there is a discussion of the 
limitations, clinical implications, and future directions for research based on this work. 
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CHAPTER 2. TRANSLATIONAL EVALUATION OF ACID/BASE AND ELECTROLYTE 
ALTERATIONS IN RODENT MODELS OF FOCAL ISCHEMIA 
Abstract 
Background and Purpose: Acid/base and electrolytes could provide clinically valuable 
information about cerebral infarct core and penumbra. We evaluated associations 
between acid/base and electrolyte changes and outcomes in two rat models of stroke, 
permanent and transient middle cerebral artery occlusion. 
Methods: Three-month old Sprague-Dawley rats underwent permanent or transient 
middle cerebral artery occlusion. Pre- and post-middle cerebral artery occlusion venous 
samples for permanent and transient models provided pH, carbon dioxide, oxygen, 
glucose, hematocrit, and hemoglobin, and electrolyte values of ionized calcium, 
potassium and sodium. Multiple regression determined predictors of infarct volume from 
these values, and Kaplan-Meier curve analyzed morality between permanent and 
transient middle cerebral artery occlusion models. 
Results: Analysis indicated significant differences in the blood gas and electrolytes 
between pre- to post-middle cerebral artery occlusion. A decrease in pH and sodium with 
increases in carbon dioxide, potassium, ionized calcium, and glucose changes were found 
in both middle cerebral artery occlusion models; while hematocrit and hemoglobin were 
significant in the transient model. pH and ionized calcium were predictors of infarct 
volume in the permanent model, as changes in pH and ionized calcium decreased, infarct 
volume increased. 
Conclusion: There are acute changes in acid/base balance and electrolytes during stroke 
in transient and permanent rodent models. Additionally, we found pH and ionized 
calcium changes predicted stroke volume in the permanent middle cerebral artery 
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occlusion model. These preliminary findings are novel, and warrant further exploration in 
human conditions. 
Introduction 
 Approximately 87% of strokes are ischemic, and are characterized by blockage of 
blood flow in the brain from a thrombus or embolus [1]. Neurological insult occurs 
immediately when the cerebral artery is occluded, as neural tissue is deprived of 
oxygenated blood, glucose, and other nutrients [2]. The penumbra, the area surrounding 
the infarct, also includes tissue at risk of cell death, and will expand to adjacent areas if 
reperfusion does not occur [2]. When there are instabilities in cerebral blood flow (CBF), 
disturbances in brain metabolism occur, causing shifts in water and ion concentrations. 
With decreasing CBF, the blood downstream of the occlusion undergoes biochemical 
changes. Disruption in blood flow reduces oxygen (O2) and glucose, and leads adenosine 
triphosphate (ATP) to be mismatched with use and production [3]. Cerebral ischemia 
occurs when cerebral O2 supply fails to meet cerebral metabolic demand. Reduction in 
CBF causes lactic acid and carbon dioxide (CO2) accumulation [4-6]. Furthermore, 
electrolyte concentrations such as sodium (Na+), calcium (Ca2+) and potassium (K+) are 
sensitive to pH changes to maintain cellular structure and function [3]. Dysregulation is 
additive, as disruption of the Na+/Ca2+ pump leads to an increased concentration of 
intracellular Ca2+ [7]. Increased calcium can trigger apoptosis, depolarization that 
activates lipases to break down neuron cell membranes, and mitochondrial dysfunction, 
leading to the generation of free radicals and reactive oxygen species (ROS) [7]. 
Several studies have investigated the relationship of venous and arterial blood gas 
parameters in critically ill human patients [8-13], and in rodent models [14, 15] 
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demonstrating correlations between the blood gas values. Knowledge of blood gases 
could provide clinically valuable information about the cerebral infarct core and 
penumbra. To date, few studies have evaluated acid/base balance and electrolyte changes 
occurring within a few minutes of focal ischemia and occlusion. The aim of our study 
was to evaluate these changes, and use these changes as predictors of infarct volume 
and/or mortality in two different rat models of stroke: permanent middle cerebral artery 
occlusion (MCAO) and transient MCAO. The permanent-MCAO model would mimic 
the natural history of large vessel occlusive stroke, while the transient-MCAO model 
accounts for recanalization seen in current treatment states that aim to re-establish flow. 
Materials and Methods 
Permanent and Transient MCAO Model 
Three-month old Sprague-Dawley rats (ENVIGO, Indianapolis, IN) were used for 
all procedures. The rats weighed between 300 and 350 grams. The study was conducted 
in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of 
Laboratory Animals and study protocols were approved through our Institutional Animal 
Care and Use Committee (IACUC). Animals were kept in a climate controlled room on a 
12-hour light and dark cycle (0700 - 1900) with free access to food and water. For both 
models, animals were administered vehicle of phosphate buffered saline (PBS) at 7.4, at 
6, 24, and 48 hours after MCAO. 
For the permanent middle cerebral artery occlusion (pMCAO) procedure, as 
previously described [16], animals were placed in an induction chamber and anesthetized 
with 5% isofluorane/oxygen. A constant flow of 3 - 4% isofluorane in 100% oxygen at a 
rate of 1 L/min was maintained during the procedure. A vertical incision was made near 
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the sternum to expose the right common carotid artery, and then a dissection was 
performed to isolate the common carotid and its branches. The first clamp was placed on 
the internal carotid prior to the pterygopalatine/internal cerebral artery (ICA) bifurcation, 
while the second clamp was placed on the common carotid artery. The placement of the 
second clamp further in the posterior direction allows more room for maneuvering during 
filament insertion. The external carotid was isolated, and used to access the arterial 
system. A 40mm nylon monofilament was fed distally into the intracranial artery to 
approximately 25mm, and then sutured in place to obtain permanent occlusion of the 
middle cerebral artery (MCA), M1 segment. The incision was closed with the filament 
in-place. A Laser Doppler (Moore Lab Instruments, Farmington, CT) monitored blood 
flow during the process. Animals that did not show 60% reduction in perfusion of blood 
flow after placement of the monofilament were excluded from the study. The transient 
MCAO (tMCAO) followed the same procedure, but the monofilament was removed and 
flow re-established after 60 minutes. The transient-MCAO rats (n = 19) were euthanized 
at 72 hours. The permanent-MCAO rats were euthanized at either 72 (n = 7) or 96 hours 
(n = 11). Brains from both models were harvested for infarct measurements.  
 Blood gas samples were collected and analyzed pre- and post-MCAO. An internal 
jugular line was inserted, prior to MCAO monofilament placement but after anesthesia 
induction, and an approximately 0.5mL of venous blood sample was collected 
(representing the pre-MCAO sample). These venous systems of the brain drains into the 
sinus of confluence which splits to form the internal jugular veins, which is the final 
collecting port before returning to the heart [17]. The majority of the venous blood 
samples were drawn on the ipsilateral side (affected MCAO side) of the animal. When 
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the blood samples at the affected site were unable to be obtained, the blood draw 
occurred on the contralateral side (unaffected MCAO side). While the ipsilateral side 
location is preferred for consistency in our blood draw protocol, the blood is analogous 
due to the venous anatomy. It takes approximately 30 minutes to obtain the blood sample 
given the details of the MCAO procedure and anesthesia induction (represented by the 
shaded box for the variable time points, Figures 2.1 and 2.2). The sample was analyzed 
using iSTAT Portable Clinical Analyzer (Abbott Laboratories, Abbott Park, IL). After 
pMCAO (approximately seven minutes), rats remained anesthetized on the operating 
table and venous blood sample was again collected (representing the post-MCAO 
sample) and analyzed with the iSTAT. pH, carbon dioxide (pCO2), oxygen (pO2), 
bicarbonate (HCO3-), base excess of extracellular fluid (beecf), glucose, and serum 
electrolytes, including ionized calcium (iCa2+), potassium (K+), and sodium (Na+) were 
analyzed. In the case of permanent MCAO, the post-MCAO sample was taken on 
average seven minutes after induction of the MCAO, while, in the case of the transient 
MCAO, the post-MCAO sample was taken approximately one hour and seven minutes 
after MCAO.  
Euthanasia and Tissue Preservation 
Animals were euthanized with Ketamine and Xylazine mixture (75 mg/kg and 7.5 
mg/kg), at 72 or 96 hours after MCAO. They were perfused with 0.9% saline, then with 
4% paraformaldehyde in PBS to remove blood from circulation and to preserve tissue. 
Brains were harvested in 4% paraformaldehyde, and then shifted to 20 to 30% sucrose for 
cryopreservation. Six coronal brain sections were cut (30µm) with a cryostat and taken 
from +1.7 to -3.3mm bregma coordinates. Coronal sections were mounted on glass slides 
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and stored at −20°C. To label degenerating neurons Fluoro-Jade staining (Histochem, 
Jefferson, AR) was used. This method has been previously detailed [18]. To rehydrate the 
coronal sections, 100% ethanol was used for three minutes, followed by a minute each in 
70% ethanol and deionized water. Sections were then Fluoro-Jade stained (0.001% 
solution in 0.1% acetic acid) for 30 minutes. Slides were rinsed and dried at 45°C for 20 
minutes, and then coverslipped with DPX mounting medium (Electron Microscopy 
Sciences, Ft. Washington, PA). 
Infarct Volume Analysis 
Coronal brain sections (bregma coordinates +1.7 through −3.3mm) were collected 
from rats in both models. A Zeiss AxioSkop2 microscope (model 801572) with a Zeiss 
AxioCam Color camera (model 412-312, Oberkochen, Germany) was used with 
OpenLab imaging software (Improvision Ltd., Lexington, MA) to capture images. Total 
infarct volumes were measured with NIH Image J software by taking the damaged 
ipsilateral hemisphere and dividing the total area of the contralateral hemisphere (six 
sections of each brain) measurement and multiplying by 100 to obtain a percentage. 
Infarct volume measurement equation: ipsilateral/contralateral x 100 = percentage. 
Statistical Analyses and Sample Size 
Before conducting statistical analyses, variables were transformed to meet 
assumptions of normality. Data from both MCAO models were analyzed using SPSS, 
version 24 software (SPSS, Inc., Chicago, IL). Data analysis began with a descriptive 
examination of all variables, including frequency distribution, means, and standard 
deviations. Paired samples t-tests were used to compare venous blood gas differences in 
mean scores between pre- and post-MCAO samples. Multiple linear regression with 
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backward variable entry was performed in the permanent and transient models to 
determine predictors based on venous blood gas and electrolyte changes to infarct 
volume. The variables were entered into the model at once. The adjusted R2 was used to 
determine the variance explained in infarct volume. The P-to-P plot was used to assess 
the changes in pH and iCa2+ data sets for normal distribution. Multicollinearity was 
assessed by examining correlation coefficients and tolerance/variance inflation factor 
values. A Kaplan-Meier curve using Mantel-Haenszel log-rank test analysis was 
performed to analyze mortality between permanent and transient-MCAO models. A p-
value of 0.05 was set a priori to determine statistical significance. 
The total sample size for the permanent MCAO model was 18. These animals are 
furthered categorized into those that survived to 72 hours (n = 11), and those that died 
prior to 72 hours (n = 7). In comparison, the total sample size for transient MCAO was 
19. These animals are also divided into those that survived to 72 hours (n = 17), and those 
that died before 72 hours (n = 2). Total sample size for both models was reduced during 
the iSTAT blood sample collection due to individual readings errors. Errors were 
excluded from statistical tests. 
Results 
Relationship Between MCAO Model and Mortality 
A Kaplan-Meier curve and Mantel-Haenszel log-rank test was used to analyze 
event-free survival between permanent and transient MCAO models (p = 0.045). 
Approximately 39% mortality was seen in the permanent model, while an average of 
11% occurred in the transient model. The mortality rates were collected at four different 
time points; 6 hours, 24 hours, 48 hours, and 72 hours. In the permanent model (n = 18), 
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seven rats died at 24 hours and 11 rats survived up to 72 hours. By comparison, the 
transient model (n = 19) rats exhibited greater survival, with one death at 6 hours and one 
other at 24 hours; the remaining animals (n = 17) survived up to 72 hours (Figure 2.3). 
The permanent-MCAO infarct volumes ranged from 24.40 to 90.79% (Figure 2.4). The 
transient-MCAO infarct volumes ranged from 12.07 to 33.34% (Figure 2.5). There is no 
significant difference in infarct size between transient and permanent occlusion. 
Permanent MCAO Model 
In the permanent MCAO model, there were several significant differences in the 
blood gas analysis between pre- and post-MCAO (Figure 2.6). These included significant 
decrease in pH (p = 0.035), Beecf (p = 0.001), and Na+ (p < 0.001), as wells as increases 
in pCO2 (p = 0.036), K+ (p = 0.006), iCa2+ (p = 0.045), and glucose (p < 0.001). Multiple 
regression analysis in the permanent-MCAO model (n = 11) showed that the changes in 
pH and in iCa2+ were significant predictors of infarct volume (F (2,8) = 16.582, p = 
0.001). This indicates a negative coefficient between pH and ionized calcium together 
with the extent of the infarct, as changes in pH and calcium decreased, infarct volume 
increased. These variables explained 76% of the total variance in the model, as predictors 
of infarct volume (Figure 2.7 and 2.8). 
Transient MCAO Model 
In the transient MCAO model, there were also several significant differences in 
blood gas analysis between pre- and post- MCAO (Figure 2.9). These included decreases 
in pH (p = 0.004) and Na+ (p = 0.002), as well as increases in pCO2 (p = 0.024); K+ (p < 
0.001), iCa2+ (p = 0.015), glucose (p = 0.047), hematocrit (p < 0.001), and hemoglobin (p 
< 0.001). Unlike the permanent model, Beecf (p = 0.397) was not significantly altered. 
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None of the acid/base changes or electrolyte changes in the transient-MCAO model were 
predictors of infarct volume. 
Discussion 
To our knowledge our study demonstrates, for the first time, rapid changes in 
venous blood gases and electrolytes occurring immediately following cerebral ischemia 
in two separate MCAO rat models (permanent and transient). Furthermore, we establish a 
statistically significant predictors between some of those changes and infarct volume. 
Significant differences were seen between the two models for mortality. Our blood 
analyses follow the biochemical changes reported in other cerebral occlusion studies in 
animals and humans. We report that significant systemic changes in blood chemistry 
occurs very rapidly after occlusion with an average of seven minutes in the permanent 
MCAO model, and approximately one hour and seven minutes in the transient MCAO 
model. To our knowledge, we have not found any other studies that examined these 
changes so early after occlusion and in two separate MCAO models. 
We used the permanent and transient MCAO models for two reasons. First, we 
aimed to identify ultra-early changes in a permanent model of ischemia. While there are a 
host of signaling cascades that occur in multiple pathways to induce injury, apoptosis, 
and necrosis after stroke, we evaluated the relationship between these ultra-early changes 
and eventual outcome. Second, we wanted to plot the course of blood gas and electrolyte 
changes upon early reperfusion. As recanalization strategies such as tissue plasminogen 
activator (tPA) and mechanical thrombectomy have become standard of care, it is 
important to understand pathologic changes in stroke in the context of acute 
recanalization. The permanent model is an evaluation of large vessel occlusive stroke in 
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its natural history [19]. The majority of patients who experience an ischemic stroke do 
not receive tPA and/or mechanical thrombectomy [20, 21]. The transient model is an 
evaluation of the effect of treatment, because it mimics the human condition for receiving 
tPA and/or mechanical thrombectomy and the reperfusion event. The transient model 
evaluates the persistency of changes in acid/base and electrolytes immediately after 
reperfusion. 
This study combined all blood measurements to determine association with infarct 
volume. In evaluating the early changes in acid/base and electrolytes in the permanent 
model the multiple linear regression showed significance in changes of pH and iCa2+ to 
infarct volume in the permanent model. These two variables clearly have an 
interrelationship to infarct volume, but causality needs to be furthered evaluated in future 
studies. 
In human stroke patients, lower venous total serum calcium concentrations were 
associated with more severe clinical symptoms following stroke onset, worse functional 
outcomes, and hemorrhagic transformation post-thrombectomy [22-24]. Conversely, 
higher venous total serum calcium levels detected on admission or within 24 hours of 
stroke onset in acute ischemic stroke patients were associated with better functional 
outcomes and reduced cerebral infarcts [25-27]. These findings reflect increased serum 
calcium levels are linked to positive stroke outcomes. Our study indicates an inverse 
relationship with changes in ionized calcium and infarct volume; however, this is based 
on immediate ionized calcium (iCa2+) changes, not total calcium serum. Furthermore, our 
measurements were within minutes to hours of the infarct induction, while the previous 
studies above included levels drawn within 24 hours of admission. Therefore, there may 
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be a calcium concentration curve that is temporal in nature as it relates to infarct. Further 
temporal studies are needed to map this relationship. 
While we found no predictors between changes in Na+ and infarct volumes, 
several reports with contradictory results show serum Na+ levels are associated with 
stroke severity in human patients. Rodrigues et al. [28] and Soiza et al. [29] found lower 
sodium or hyponatremia was associated with stroke severity and mortality. Other studies 
have observed higher venous serum sodium concentrations were associated with stroke 
incidence and neurological worsening [30-32]. Serum Na+ levels in the control group was 
lower than in patients with transient ischemic attack, and with ischemic and hemorrhagic 
strokes [33]. Our findings are similar in showing changes in serum Na+ levels from pre-to 
post- pMCAO, but the significance of these changes needs to be elucidated. Again, the 
timing of sampling may have an effect on the power of the association. It may be the case 
that our early-timed assay does not reflect changes that occur in the first 24 to 48 hours. 
The transient MCAO model did not show predictors in the multiple linear 
regression model. We believe this is due to the magnitude of the changes of acid/base and 
electrolytes may be masked by the benefit of reperfusion. While we saw many similar 
differences in changes from pre- to post-MCAO (compared to the permanent model), the 
animals did not have any predictors of infarct volume. This may reflect the overpowering 
effect of recanalization and reperfusion on dictating final infarct volume. Further studies 
will need to be conducted to address these issues. 
Another interesting difference between the two models was noting the significant 
differences of increased hematocrit and hemoglobin pre- to post-MCAO in the transient 
model, most likely due to hemoconcentration of fluid losses (urination, temperature or 
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insensible losses), which is often seen in human ischemic stroke patients. This was not 
observed in the permanent model perhaps due to the timing of the second iSTAT 
collection, where animals may not have had an opportunity to compensate yet; these are 
issues that need to be addressed in future studies. 
The transient model had better survival rate than the permanent model. The 
permanent model shows animal deaths occurred at various time points post-MCAO with 
the majority occurring at 24 hours. The 24-hour time point is critical in human ischemic 
stroke patients because this is the period when patients experience edema, herniation, and 
hemorrhagic conversion resulting in increased mortality [34] We did not find this in the 
transient model, which verifies the importance of reperfusion in ischemic stroke and 
survival outcomes. 
Conclusion 
In this study, we demonstrated early significant changes in blood gases and 
electrolyte concentrations after induction of a middle cerebral artery occlusion stroke. 
This study shows that blood chemistry in the systemic circulation responds rapidly to the 
ischemic event in the brain. Other studies examined one stroke model and one blood gas 
parameter or electrolyte concentration, while we analyzed two separate MCAO models in 
rats and the whole blood gas and electrolyte panel. Previous researchers have shown 
variability in their results, however, our study shows the initial changes in pH and ionized 
calcium are predictors of infarct volume in the permanent MCAO model. Our future 
studies will examine aged male and female rats to address whether age and sex affects 
this issue. Eventually we are planning to expand our blood gas studies to humans to 
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determine if these results translate to human stroke patients, which would allow early 
prediction of the stroke outcome. 
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Table 2.1: Permanent Model 








Mean ± SD 
Post-MCAO 
Mean ± SD 
D 
Mean ± SD 
 
P-value 
pH 14 7.249 ±  0.071 7.217 ± 0.075 0.033 ± 0.052 0.035 
pCO2 
(mmHg) 
14 68.660 ± 9.397 75.890 ± 
14.190 









-1.429 ± 18.711 0.780 
BEecf 
(mmol/L) 
14 4.360± 1.008 3.070 ± 1.328 1.286 ± 1.069 0.001 
HCO3- 
(mmol/L) 









1.643 ± 1.216 <0.001 
K+ (mmol/L) 14 4.450 ± 0.231 4.711 ± 0.408 -0.261± 0.296 0.006 
iCa2+ 
(mmol/L) 












Hct (% PCV) 14 40.214 ± 1.424 40.429 ± 1.651 -0.214 ± 0.893 0.385 
Hbg (g/dL) 14 13.679 ± 0.474 13.743 ± 0.543 -0.064 ± 0.295 0.430 
Data are presented as mean ± standard deviations. Blood gas and electrolyte parameters: 
pCO2: Partial pressure of carbon dioxide (mmHg); pO2: partial pressure of oxygen 
(mmHg); HCO3-: bicarbonate (mmol/L); BD: base deficit (mmol/L); BE: base excess 
(mmol/L); sO2: oxygen saturation (%); Na+: sodium (mmol/L); K+: potassium 
(mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose (mg/dL); Hct: hematocrit (% 




Table 2.2: Permanent Model 
Multiple regression was performed to determine the correlations of venous blood gas and 
electrolyte changes to infarct volume. As changes in pH and ionized calcium decrease, 
infarct volume increases. These variables explained » 76% of the total variance in the 
model as predictors of infarct volume in the permanent model. 
 
Variable B SE B β p value 
DpH -86.155 21.050 -0.640 0.003 
DiCa2+ -99.878 22.994 -0.679 0.002 






Table 2.3: Transient Model Venous blood paired samples T-Test in pre- and post- MCAO 








Mean ± SD 
Post-MCAO 
Mean ± SD 
D 
Mean ± SD 
 
P-value 
pH 12 7.263 ±  0.060 7.106 ± 0.143 0.157 ± 0.152 0.004 
pCO2 
(mmHg) 
9 71.490 ± 
14.155 
















9 4.440 ± 1.810 4.110 ± 1.537 0.333 ± 1.118 0.397 
HCO3- 
(mmol/L) 
9 31.310 ± 1.745 32.270 ± 2.502 -0.956 ± 1.731 0.136 
Na+ (mmol/L) 12 133.83 ± 1.030 131.830 ± 1.749 2.000 ± 1.758 0.002 
K+ (mmol/L) 12 4.342 ± 0.144 4.933 ± 0.485 -0.592 ± 0.414 <0.001 
iCa2+ 
(mmol/L) 












Hct (% PCV) 12 39.000 ± 1.595 41.750 ± 2.137 -2.750 ± 1.138 <0.001 
Hbg (g/dL) 12 13.250 ± 0.525 14.200 ± 0.727 -0.950 ± 0.397 <0.001 
Data are presented as mean ± standard deviations. Blood gas and electrolyte parameters: 
pCO2: Partial pressure of carbon dioxide (mmHg); pO2: partial pressure of oxygen 
(mmHg); HCO3-: bicarbonate (mmol/L); BD: base deficit (mmol/L); BE: base excess 
(mmol/L); sO2: oxygen saturation (%); Na+: sodium (mmol/L); K+: potassium 
(mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose (mg/dL); Hct: hematocrit (% 





Figure 2.1 Permanent-MCAO Timeline. 
 
Figure 2.2 Transient-MCAO Timeline. 
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Figure 2.3 Mortality data expressed using the Kaplan-Meier curve and analysis using the 
Mantel-Haenszel log-rank test revealed significant difference in survival between 
permanent and transients (p = 0.045). The numbers in parentheses represent the mortality 
of rats at 24 hours and 48 hours. The surviving rats in the permanent model were n=11. 





Figure 2.4 Representative permanent-MCAO infarct volume image. Fluoro-Jade staining 
was performed on cryosections from rat brains to identify the damaged neurons 72 hours 
post-MCAO. The range for permanent-MCAO infarct volumes were 24.40 – 90.79%. 
Scale bars =150µm. 
 
 
Figure 2.5 Representative transient-MCAO infarct volume image. Fluoro-Jade staining 
was performed on cryosections from rat brains to identify the damaged neurons 72 hours 






Figure 2.6: Permanent Model 
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CHAPTER 3. EARLY ACID/BASE AND ELECTROLYTE CHANGES IN PERMANENT MIDDLE 
CEREBRAL ARTERY OCCLUSION: AGED MALE AND FEMALE RATS 
Abstract 
Background: Early changes in acid/base and electrolyte concentrations could provide 
insights into the development of neuropathology at the onset of stroke. We evaluated 
associations between acid/base and electrolyte concentrations, and outcomes in 
permanent middle cerebral artery occlusion (pMCAO) model. 
Methods: 18-month old male and female Sprague-Dawley rats underwent pMCAO. Pre-, 
post- (7 minutes after occlusion), and at 72 hours of pMCAO venous blood samples 
provided pH, carbon dioxide, oxygen, glucose, hematocrit, hemoglobin, and electrolyte 
values of ionized calcium, potassium and sodium. Multiple linear regression determined 
predictors of infarct and edema volumes from these values, Kaplan-Meier curve analyzed 
morality between males and females at 72 hours, and a Cox regression model was used to 
determine predictors for mortality. 
Results: Analysis indicated significant differences in acid/base balance and electrolyte 
levels in aged rats not dependent on sex between the three time points in the pMCAO 
model. Changes in pH (from pre- to post and post- to 72 hours) and changes in sodium 
and ionized calcium (from post- to 72 hours) were predictors of infarct volume and 
edema volume, respectively. Cox Regression revealed there is a 3.25 times increased risk 
for mortality based on changes in bicarbonate (pre- to post-MCAO). 
Conclusions: These early venous blood changes in acid/base balance and electrolytes can 
be used to predict stroke outcomes in our rat model of stroke. This study provides 
potential biomarkers to be examined in the human condition that could provide profound 




Stroke remains the leading cause of death and disability worldwide [1]. Edema 
and electrolyte imbalance contribute to brain swelling, dysfunction, and death. Currently, 
there are no early serum tests to predict risk of death from stroke-induced edema. While 
MRI will show large infarcts early, it is no longer typically used in the emergent 
presentation due to delaying urgent treatment. Therefore, identifying an easily obtainable 
clinical marker to predict cerebral edema and death would be a major advancement in 
stroke care. Many strokes are emergent large vessel occlusion (ELVO), in which there is 
an acute occlusion of one of the vessels of the Circle of Willis. Accounting for 20-40% of 
ischemic strokes, it is the most disabling form [2]. The permanent MCAO model best 
represents the natural history of emergent large vessel occlusion (ELVO) stroke that is 
untreated with thrombolytic therapy or mechanical thrombectomy [3]. Most patients with 
ELVO currently do not receive either of these treatments, which results in a high 
mortality rates or severe disabilities [4, 5]. 
Blockage of the large vessel artery reduces cerebral blood flow (CBF) below 
functional levels depriving neurons of oxygenated glucose and blood. The penumbra, the 
brain area adjacent to the infarction, is at risk of infarction if reperfusion does not occur 
[6]. Oxygen (O2) and glucose are reduced in the blood downstream of the occlusion. A 
deprivation in O2 and glucose contribute to the failure of adenosine triphosphate (ATP) 
production and cerebral ischemia occurs when O2 supply fails to meet metabolic demand 
[7]. Cells are forced into anaerobic glycolysis which leads to lactic acid accumulation, 
which lowers the pH [8, 9]. Carbon dioxide (CO2) builds up and accumulates in 
extracellular and intracellular spaces leading to decrease in pH [10]. The acidic pH 
31 
 
impacts electrolyte concentrations such as sodium (Na+), calcium (Ca2+) and potassium 
(K+) which regulate cellular structure and function [7]. Increased concentration of 
intracellular Na+ causes cytotoxic edema. Additionally, the disruption of the Na+/Ca2+ 
pump results in an increased concentration of intracellular Ca2+ which initiates apoptosis, 
causes mitochondrial dysfunction, and generates free radicals and reactive oxygen 
species (ROS) [11]. These acid/base and electrolyte changes are associated with the 
severity of the stroke [12], a greater understanding of the blood gas parameters allows us 
further insight into how these factors influence stroke outcomes.  
Previously, we have reported a change in blood gases and electrolytes within a 
few minutes of focal ischemia in young male rats and these changes predict infarct 
volume [12]. This study uses aged male and female rodents that are better aged-matched 
to the typical age of the human stroke patient. Therefore, we aimed to examine venous 
blood gas values in male and female aged rats at three time points: (1) pre-permanent 
middle cerebral artery occlusion (pMCAO), (2) post-pMCAO, and (3) at 72 hours before 
euthanization to determine whether venous blood gas values predict infarct volume, 
edema volume, and/or mortality in pMCAO. This study identifies early changes in blood 
gases/electrolytes that predict stroke outcomes in an experimental rodent model of stroke. 
Materials and Methods 
Ethics Approval and Animals 
Aged male and female rats (18-month old Sprague-Dawley rats (ENVIGO, 
Indianapolis, IN) were used for all procedures. The aged female rats on average weighed 
between 245 and 425 grams, and aged male rats approximately weighed between 505 to 
705 grams. The study was conducted in accordance with the National Institutes of Health 
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(NIH) Guide for the Care and Use of Laboratory Animals and study protocols were 
approved by University of Kentucky’s (UK) Institutional Animal Care and Use 
Committee (IACUC). Animals were housed in a climate controlled room on a 12-hour 
light and dark cycle (0700 - 1900) with access to food and water. Per Division of 
Laboratory Animal Resources (DLAR) cage requirements at UK’s vivarium facility, the 
animals can be paired in one cage if the animal weight is under 650 grams. We typically 
house two animals (males or females) per cage upon arrival to DLAR. Once the rats are 
over 650 grams, they are then split into a separate cage by themselves. Animals were 
administered vehicle of sterile filtered phosphate buffered saline (PBS) of pH 7.4, at 6, 
24, 48, and 72 hours after permanent middle cerebral occlusion (pMCAO). The rats that 
survived to 72 hours (n = 16) underwent Magnetic Resonance Imaging (MRI) for 
Diffusion Tensor Imaging (DTI) images and T2 weighted images to measure infarct and 
edema volumes and then euthanized. 
Permanent Middle Cerebral Artery Occlusion 
During the pMCAO procedure, as previously described [13], animals were placed 
in an induction chamber and anesthetized with 5% isofluorane/oxygen. During the 
procedure, a constant flow of 3% isofluorane in 100% oxygen at a rate of 1 L/min was 
maintained. A midline vertical neck incision occurred to collect an internal jugular blood 
draw. Glass rods were used to separate the large muscle pad and the sternocleidomastoid 
muscle (SCM). Retractors were placed to pull musculature of the SCM and skin tightly 
away from the targeted area. Dissection of the omohyoid muscle, fat, and connective 
tissues were made to isolate and expose the right common carotid artery from the vagus 
nerve. Blunt dissection with glass rods occurred around the internal carotid artery (ICA) 
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with removal of lymph nodes and fat surrounding the internal/external cerebral artery 
(ICA/ECA) bifurcation to expose the pterygopalatine/middle cerebral artery (MCA) 
bifurcation. The first clamp was placed on the ICA prior to the pterygopalatine/MCA 
bifurcation, while the second clamp was placed on the common carotid artery (CCA). 
The placement of the second clamp further in the posterior direction allows more room 
for manipulation during the embolus insertion. The ECA was isolated, and used to access 
the arterial system. A 40mm nylon monofilament was fed distally into the ECA and 
advanced through to the ICA at approximately 25mm until it reached the ICA clamp. The 
monofilament was loosely sutured in place, the first clamp was removed, and the 
embolus was advanced then sutured in place to obtain permanent occlusion of the middle 
cerebral artery (MCA), M1 segment. The second clamp was removed with careful 
observation of minimal blood, then the removal of the retractors. Before the neck incision 
closure, a post-MCAO blood draw occurred from the internal jugular vein. 
Post-Surgical Fluid Management and Pain Control 
Immediately post-operatively the animals received 2ml of sterile saline (0.9%) 
subcutaneous. An additional 1ml of saline was given if extra blood loss occurred during 
surgery. The animals were injected with sterile filtered PBS pH 7.4 at 6, 24, 48, and 72 
hours post-MCAO. The animals were weighed every morning post-MCAO to determine 
dehydration. Hydration status was checked by pinching up or “tenting” the skin over the 
nape of the neck. The skin should immediately relax into its normal position. If the skin 
remains tented longer than normal, the rat was deemed dehydrated and saline was given. 
Per DLAR guidelines, rats can receive up to 10ml at a time and no more than 2ml at any 
one location per 6 hours. If warranted, additional saline (1-2ml) will be given in addition 
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to 6, 24, 48, and 72 hours. Also, we added an additional water bottle in each cage to 
allow more availability to free water and moist food to encourage feeding and additional 
water intake. 
Post-surgical pain control was managed with carprofen, which is based on weight 
of the animal. Animal weights are taken prior to surgery (pMCAO) and daily until 
animals are euthanized at 72 hours (post MRI). The animals received a dosage of 
carprofen 5mg/kg prior to surgery and every 24 hours for three days post-pMCAO until 
72 hours when they were euthanized (post MRI). 
Venous Blood Gas Collection 
Blood gas samples were collected and analyzed pre- and post-MCAO, and prior 
to euthanization at 72 hours. The venous blood sample was analyzed using iSTAT 
Portable Clinical Analyzer (Abbott Laboratories, Abbott Park, IL) for pH, carbon dioxide 
(pCO2), oxygen (pO2), bicarbonate (HCO3-), base excess of extracellular fluid (Beecf), 
glucose, hematocrit, hemoglobin, and serum electrolytes, including ionized calcium 
(iCa2+), potassium (K+), and sodium (Na+). Individual readings errors and these errors 
were excluded from statistical tests. An internal jugular line was inserted, prior to MCAO 
monofilament placement and an approximately 100µl of venous blood sample was 
collected (representing the pre-MCAO sample, Figure 3.1). The venous circulation drains 
into the confluence of the sinuses and then splits into right and left internal jugular veins 
before recirculation through the heart [14]. Venous blood samples were collected from 
the affected MCAO side of the animal. However, in certain cases venous blood samples 
were collected from the contralateral side (unaffected MCAO side). The pre-pMCAO 
blood sample takes approximately 30 minutes to obtain given the details of the procedure 
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and anesthesia induction (represented by the shaded box for the variable time points, 
Figure 3.1). Post-MCAO (approximately taken within seven minutes of occlusion), rats 
remained anesthetized on the operating table and venous blood sample was again 
collected (representing the post-MCAO sample). The third venous blood sample was 
collected from the right atrium (Figure 3.1) in animals that survived to 72 hours. 
Magnetic Resonance Imaging 
MRI images were acquired on a 7T Bruker Clinscan horizontal bore system (7.0T, 
30cm, 300Hz) equipped with a triple-axis gradient system (630 mT/m and 6300 T/m/s) 
with a closed cycle. Diffusion Tensor Imaging (DTI) images were acquired coronally 
with a fat saturated, double refocused echo planar sequence: 0.297 x 0.297 x 0.7 mm3, 
TR/TE 2200/34, 128 x 128 matrix, 3 av, 12 slices, four b=0 volumes, 256 directions with 
b=800, in 28:23 minutes (Figure 3.2.A). T2 weighted images were acquired coronally 
with a fat saturated, turbo spin echo sequence: 0.125 x 0.125 x 0.4 mm3 resolution, 
TR/TE 6000/27, 192 x 192 matrix, 44 slices, is 9:03 (Figure 3.2.C).  
Male rats were anesthetized with an average of 2.25% isoflurane in oxygen, while 
female rats were anesthetized with an average of 1.75% isoflurane in oxygen using an 
MRI compatible CWE Inc. equipment (Ardmore, PA). They were held in place on a 
Bruker scanning bed with a tooth bar, ear bars, and tape. Body temperature, heart rate, 
and respiratory rates were continuously monitored throughout the MRI scans (SA 
Instruments, Inc., Stony Brook, NY). The animal’s body temperature were maintained at 
37°C with a water heating system built into the scanning bed. The scanning procedure 




MRI Processing for Infarct Volume and Edema Volume 
The DTI and T2 MR images were analyzed by a blinded neuroradiologist who 
identified infarct volume and edema volume. These volumes were counted and the 
number referenced to the number of images counted to provide a per section count. The 
volume of brain parenchyma demonstrating restricted diffusion (infarct volume) visibly 
affected were calculated by manual segmentation using ITK-SNAP software 
(www.itksnap.org, version 3.6, Figure 3.2.B) [15]. The volume of brain parenchyma 
visibly affected by cerebral edema (edema volume) were calculated in a similar fashion 
(Figure 3.2.D). The data are given as absolute volume in cubic millimeters. The 
calculation was based on all slices from each MR sequence. 
Statistical Analysis 
Data analysis began with a descriptive examination of all variables, including 
frequency distribution, means, and standard deviations. The power analysis was 
completed using G*Power software [16, 17]. Given a desired power of 0.8 and a 
significance level for between-group comparisons set at p < 0.05, the required sample 
size was calculated to be 14 animals (i.e., n = 7 per group). All variables in the study 
were transformed to meet assumptions of normality. The transformation procedures 
began with Shapiro-Wilks and for measures with p < 0.05, natural log with a constant of 
10 added to measure. Data from the aged male and female rats were analyzed using 
SPSS, version 24 software (IBM, Armonk, NY).  
A repeated-measures analysis of variance (ANOVA) was used to examine 
between-group differences of blood gas parameters of the sexes at three time points, pre-
MCAO, post-MCAO, and at 72 hours-MCAO. Paired samples t-test were used to 
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compare venous blood gas mean values between pre- and post-MCAO for the animals 
that died prior to 72 hours, in addition to an independent t-test to compare venous blood 
gas mean values between pre-MCAO animals that survived versus died prior to 72 hours. 
A multiple linear regression with backward variable entry was performed with magnitude 
of change data from aged male and female rats to determine whether venous acid/base 
and electrolyte changes predicted infarct volume and/or edema volume. The variables 
were entered into the regression model in one step. The adjusted R2 was used to 
determine the variance explained in infarct volume and/or edema by each variable. An 
assessment of multicollinearity was performed by inspecting correlation coefficients and 
tolerance/variance inflation factor values. Inspecting the coefficients table and if 
tolerance values are less than 0.10 or VIF is above 10, collinearity is present and was not 
found in final model. The P-to-P plot was used to assess the changes in pH, iCa2+, and 
Na+ data sets for normal distribution. A Kaplan-Meier curve using Mantel-Haenszel log-
rank test analysis was performed to compare survival curves between aged male and 
female rats. A Cox regression curve was used to assess the relationship of event-free 
survival in aged male and female rats using predictors of acid/base and electrolyte 
concentration parameters. A p-value of 0.05 was set a priori to determine statistical 
significance. 
Sample Size 
The total sample size from the permanent MCAO model were 31. These animals 
are furthered categorized into those that survived to 72 hours (n = 16; males = 7 and 





Acid/Base and Electrolyte Values for Survival 
Venous Blood Gas Differences Between Aged Male and Female Rats 
A repeated-measures analysis of variance (ANOVA) was used to examine 
between-group differences of blood gas parameters of the sexes at three time points, pre-
pMCAO, post-MCAO, and at 72 hours-MCAO (Table 3.1). Mauchly’s test indicated that 
the assumption of sphericity had been violated for each blood gas parameter therefore 
degrees of freedom were corrected with Greenhouse-Geisser estimates of sphericity 
(Table 3.2). There was not a significant interaction of time by group effect between the 
three time points of blood gas parameters and sex (Table 3.3). 
Acid/Base and Electrolyte Values for Death 
Because there were no baseline differences between males and females rats that 
died prior to 72 hours their data were collapsed into a single group. There were 
significant differences in blood gas values seen from pre- to post-MCAO in animals that 
died prior to 72 hours (n = 15, Table 3.4). pH (p = 0.026) and Na+ (0.039) decreased from 
pre- to post-MCAO, while pCO2 (p = 0.015), HCO3- (p = 0.001) and glucose (p = 0.014) 
increased. There were no significant differences seen in baseline (pre-MCAO) values 
from those animals that survived and those that died prior to 72 hours (Supplemental 
Table 3.1). 
Predictors of Infarct Volume and Edema Volume 
Blood gas and electrolyte changes from male and female rats were combined for 
multiple linear regression analyses. Multiple regression analysis (n = 15) showed that the 
changes in pH from pre- to post-MCAO and in pH from post to 72 hours-MCAO were 
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predictors of infarct volume (F (2,14) = 14.77, p = 0.030). These variables explained 81% 
of the total variance in the model (Table 3.5). 
Multiple regression analysis (n = 16) revealed that the changes in iCa2+ from post 
to 72 hours-MCAO and Na+ post to 72 hours-MCAO were predictors of edema volume 
(F (2,15) = 12.32, p = 0.015). These variables explained 75% of the total variance in the 
model (Table 3.6). The mean infarct size is 203.64 ± 61.41, while the mean edema 
volume is 124.04 ± 41.39. There was no significant difference (p = 0.524) in infarct size 
between aged male (n = 6) and female rats (n = 9) or in edema volume (p = 0.730) 
between aged male (n = 7) and female rats (n = 9). 
Relationship Between MCAO and Mortality 
A Kaplan-Meier curve with Mantel-Haenszel log-rank test was used to analyze 
event-free survival between aged male and female rats. There was no difference between 
male and female rats based on mortality (p = 0.321, data not shown). In the Cox 
regression, there a 3.25 times (or 325%) greater risk for mortality for rats within the -2.00 
to -7.00 cut-off range for HCO3- (pre- to post-MCAO), after controlling for change in Na+ 
and sex (p = 0.025) (Figure 3.3). 
Discussion 
Previously, we have reported that changes in venous blood pH and ionized 
calcium (pre- to post-MCAO) predicted infarct volume in young male rats [12]. We now 
extend our findings to aged male and female rats after pMCAO. The venous blood gas 
profile after pMCAO significantly differed between the young and aged. Our aged rats 
(18 months equivalent to approximately 55-65 years old in humans [18]) are a better age 
match for human stroke patients. A major issue in stroke research is the lack of 
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translating findings from the rodent to the human patient. The almost uniform use of 
young male rats in stroke research is one of the contributing factors for this problem. Our 
expectations were that data acquired from aged rats should be more translatable to human 
stroke. While we did not find any differences in the venous blood between the sexes, we 
use both sexes to better reflect the human population. Gender-specific responses to stroke 
therapies are well-documented, and most recently exemplified in the experience with the 
clinical trial showing that uric acid is effective with females but not male stroke patients 
[19].  
These changes in pH taken together are predictors that affect infarct volume. The 
importance of this finding occurring in the post-MCAO to 72-hour mark is important for 
translational studies, because this period would be the most applicable as a prognostic 
tool for the human patient. The pH is tightly regulated in the blood and other tissues to 
maintain homeostasis. The accumulation of lactic acid and CO2 in ischemic brain disrupts 
the normal pH balance [9]. Our study showed significant changes of pH as a predictor of 
infarct volume, but interestingly, a predictor that varied depending on the time point pH 
was measured. At the first timepoint (from pre- to post- MCAO), our results demonstrate 
that as changes in pH increased, infarct volume increased. At the second timepoint (from 
post-MCAO to 72 hours), as changes in pH increased, infarct volume decreased. 
Carbon dioxide and water are catalyzed by carbonic anhydrase, which results in 
the generation of bicarbonate and H+ [20]. The H+ proton facilitates transport of Na+ 
across membranes. Other electrolytes and water follow the transport of Na+ during 
ischemia, causing malignant cerebral edema. Bicarbonate production is low in blood 
under alkaline conditions, and is high in acidic conditions found in ischemia. Its purpose 
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is to regulate pH homeostasis, and to facilitate anion/water transport. In heart ischemia 
reperfusion, the presence of bicarbonate causes increased oxidative damage [21], which 
leads to increased inflammation. While ELVO causes significant injury to the affected 
brain, the associated malignant edema injures surrounding otherwise unaffected brain, 
caused herniation and death [22]. These early changes in bicarbonate predict mortality of 
aged rats of both sexes and provides a potential biomarker to be explored in human stroke 
patients. 
We have also identified predictors related to edema, which can be a lethal 
consequence of cerebral infarction. Changes in ionized calcium and sodium post-MCAO 
to 72 hours predicted for edema volume. We found an inverse relationship, as changes in 
ionized calcium and sodium (post-MCAO to 72 hours) to edema volume, as ionized 
calcium and sodium increased, edema volume decreased. To our knowledge neither 
ionized calcium, nor sodium were previously reported to affect edema volume as a stroke 
outcome. They are, however, discussed in connection with infarct volume, patient 
functional outcomes, and mortality. In human stroke patients, severe clinical presentation 
was seen after stroke onset, as was worsening of functional outcomes, and the potential 
for hemorrhagic conversion post-thrombectomy; these were associated with lower total 
serum calcium concentrations in peripheral venous blood [23-25]. Conversely, better 
functional outcomes and decreased infarcts were associated with higher venous total 
serum calcium levels [26-28]. These findings link positive stroke outcomes to increased 
serum calcium levels. Yet, also seen in human stroke patients were inconsistent results of 
associations between serum Na+ levels and stroke severity. Patients with increased stroke 
severity and mortality exhibited associations with hyponatremia or lower Na+ levels [29, 
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30]. While others found associations between increase stroke incidence and neurological 
worsening with higher venous serum Na+ concentrations [31-33]. However, these studies 
relied on univariate analyses so multivariate analyses appear to add more understanding 
of the associations of biomarkers with functional or neurological outcomes. 
The Cox regression showed changes in bicarbonate levels were also an important 
predictor for increased risk for mortality. Bicarbonate is important for pH, electrolyte, 
and water balance, which is disturbed during ischemic stroke. Bicarbonate levels changed 
rapidly after inserting the embolus into the internal carotid artery to block the middle 
cerebral artery, approximately within 7 minutes. Our data show that the physiological 
buffering response of the rats is impaired post-pMCAO; they are unable to adjust their 
blood homeostasis, leading to mortality. To our knowledge, this is the earliest change in 
bicarbonate measurement after experimental stroke to be reported. Moreover, this finding 
shows that there are two rat subpopulations. One is able to regulate bicarbonate and 
survive and other unregulated bicarbonate levels increased probability of death by 328%. 
If translated to humans, this would suggest that early bicarbonate levels could inform 
treatment for the patient after stroke. 
There is, however, some distinction between the pMCAO model in young and 
aged rats in acid/base balance and electrolyte concentrations as predictors of infarct 
volume. In our previous paper, we discovered as changes in pH and ionized calcium 
(from pre- to post-MCAO) increased, infarct volume decreased in young male rats [12]. 
This finding is inverse from results related to aged rats, which show that as changes in pH 
(from pre- to post-MCAO) increased, infarct volume increased. We also previously found 
that as changes in ionized calcium (from pre- to post- MCAO) increased, infarct volume 
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decreased. These changes were not found in aged rats, rather there was an association 
with changes in ionized calcium at a different time point (post-MCAO to 72 hours) with 
an increase in edema volume. The differences between young and aged rats demonstrate 
that some blood gas and electrolyte parameters are age dependent, while others are not. 
Translation of findings from rodent to human has been problematic in stroke research 
with the almost exclusive use of young male rats. As demonstrated by this study, 
differences in the response to stroke arise between young and aged rats. These aged rats 
are a closer age match to human stroke patients and could be a better model for 
translation to humans. 
The physiological significant of this study is that the response to ischemia is rapid 
within minutes. Water movement is associated with transport of electrolytes, primarily 
with sodium. Our data indicate that if the brain is able to maintain the electrolytes, 
ionized calcium and sodium, within the blood then edema is reduced. This study suggests 
infarct volume and death may occur if buffering in the blood is unable to maintain blood 
homeostasis. The maintenance of pH is essential as acidosis will result in neural cell 
death to expand the infarct volume [15, 34, 35]. Bicarbonate, as discussed above, plays a 
critical role in maintaining blood homeostasis and the dysregulation of bicarbonate. In 
fact, serum bicarbonate is associated with heart failure and mortality [36]. 
Conclusion 
In conclusion, we showed shows that blood chemistry in the systemic circulation 
responds rapidly to an ischemic event in the brain. Of the three time points used, the post-
MCAO and 72-hour time points would be most applicable to the human stroke patients 
since they receive treatment hours after having a stroke. Finally, bicarbonate stands out as 
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the most promising indicator from our study, providing us with a predictive range for 
mortality but must be examined in the context of the human patient. Overall, these studies 
will provide acid/base and electrolyte concentrations as potential predictive biomarkers 
for stroke outcomes. These studies need be verified in human patients an at appropriate 
time points in patient care. However, the use of multivariate analyses appears to be more 
appropriate approach in determining predictive biomarkers. 
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Table 3.1: Venous blood gas analyses at pre-, post-, and 72 hours pMCAO in aged male 




Mean ± SD 
Male 
Mean ± SD 
Female 








7.30 ±  0.04 7.32 ± 0.04 7.29 ± 0.03 0.125 
7.23 ±  0.07 7.27 ±  0.04 7.20 ±  0.06  






60.11 ±  6.29 58.38 ± 6.58 61.27 ± 7.23 0.213 
77.08 ±  6.77 71.05 ±  6.94 81.10 ±  6.06  






125.33 ± 13.87  127.00 ± 11.24 123.22 ± 15.56 0.409 
103.33 ± 14.72 102.50 ±  16.67 103.89 ± 12.21   






3.33 ±  0.49 4.50 ± 0.64 3.56 ± 0.35 0.612 
4.80 ±  0.27 5.33 ± 0.36 3.78 ± 0.20  






29.95 ± 1.59 30.35 ± 1.26 29.69 ± 1.83 0.317 
31.65 ± 2.03 32.27 ± 1.43 31.23 ± 2.34  






137.60 ± 1.51 137.17 ± 1.72 137.89 ± 1.36 0.774 
136.00 ± 1.56 135.67 ± 1.37 137.22 ± 1.72  






3.73 ± 0.34 3.97 ± 0.21 3.57 ± 0.32 0.871 
3.87 ± 0.30 4.03 ± 0.31 3.77 ± 0.27  






1.01 ± 0.16 1.01 ± 0.11 1.02 ± 0.19 0.673 
1.03 ± 0.13 1.07 ± 0.15 1.01 ± 0.12  






223.67 ± 22.67 237.67 ± 19.52 214.33 ± 24.81 0.712 
346.87 ± 36.26 357.67 ± 33.87 339.67 ± 38.36  





Table 3.1 (continued). 





40.13 ± 2.13 42.33 ± 2.07 38.67 ± 2.24 0.268 
41.23 ± 2.65 42.67 ± 2.80 39.45 ± 2.42  






13.65 ± 0.76 14.40 ± 0.71 13.14 ± 0.77 0.158 
13.65 ± 0.68 14.53 ± 0.57 13.07 ± 0.72  
11.99 ± 1.48 13.63 ± 1.20 10.90 ± 1.63  
Data are presented as mean ± standard deviations. Total sample size N = 16; n = 7 male 
rats, n = 9 female rats. P values represent the interaction of 3 time points x gender. Blood 
gas and electrolyte parameters: pCO2: Partial pressure of carbon dioxide (mmHg); pO2: 
partial pressure of oxygen (mmHg); HCO3-: bicarbonate (mmol/L); BD: base deficit 
(mmol/L); BE: base excess (mmol/L); sO2: oxygen saturation (%); Na+: sodium 
(mmol/L); K+: potassium (mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose 





Table 3.2: Mauchly’s test indicated that the assumption of sphericity had been violated 
for each blood gas parameter therefore degrees of freedom were corrected with 








Estimate of Sphericity 
 
Significance 
     
pH 22.26 2 e = 0.678 p <0.001 
pCO2 23.49 2 e = 0.791 p <0.001 
pO2 20.45 2 e = 0.550 p <0.001 
HCO3- 15.61 2 e = 0.579 p <0.001 
Beecf 17.75 2 e = 0.564 p <0.001 
Na+ 13.64 2 e = 0.596 p <0.001 
K+ 11.05 2 e = 0.517 p <0.001 
iCa2+ 12.26 2 e = 0.502 p <0.001 
Glu 8.31 2 e = 0.667 p = 0.016 
Hct 15.98 2 e = 0.569 p <0.001 
Hbg 17.06 2 e = 0.572 p <0.001 
Blood gas and electrolyte parameters: pCO2: Partial pressure of carbon dioxide 
(mmHg); pO2: partial pressure of oxygen (mmHg); HCO3-: bicarbonate (mmol/L); BD: 
base deficit (mmol/L); BE: base excess (mmol/L); sO2: oxygen saturation (%); Na+: 
sodium (mmol/L); K+: potassium (mmol/L); iCa2+: ionized calcium (mmol/L); Glu: 




Table 3.3: There was not a significant interaction effect between the three time points of 
blood gas parameters and sex. 
Variable F df Significance 
    
pH 2.27 2 p = 0.125 
pCO2 1.64 2 p = 0.213 
pO2 1.17 2 p =0.409 
HCO3- 1.12 2 p = 0.317 
Beecf 0.31 2 p = 0.612 
Na+ 0.12 2 p = 0.774 
K+ 0.14 2 p = 0.871 
iCa2+ 0.39 2 p = 0.673 
Glu 0.22 2 p =0.712 
Hct 1.75 2 p = 0.268 
Hbg 1.39 2 p = 0.158 
Blood gas and electrolyte parameters: pCO2: Partial pressure of carbon dioxide (mmHg); 
pO2: partial pressure of oxygen (mmHg); HCO3-: bicarbonate (mmol/L); BD: base 
deficit (mmol/L); BE: base excess (mmol/L); sO2: oxygen saturation (%); Na+: sodium 
(mmol/L); K+: potassium (mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose 
(mg/dL); Hct: hematocrit (% PCV); and Hbg: hemoglobin (g/dL). 
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Table 3.4: Pre- and post-MCAO acid/base and electrolyte values for animals that died 






Mean ± SD 
Post-MCAO 
Mean ± SD 
 
P-value 
pH 15 7.31 ±  0.05 7.19 ± 0.12 0.026 
pCO2 (mmHg) 15 58.54 ± 4.80 91.13 ± 6.09 0.015 
pO2 (mmHg) 15 121.29 ± 14.41 119.57 ± 13.72 0.686 
Beecf (mmol/L) 15 3.50 ± 0.52 3.52 ± 0.55 0.919 
HCO3- (mmol/L) 15 29.50 ± 2.24 35.67 ± 2.36 0.001 
Na+ (mmol/L) 15 137.19 ± 1.60 134.00 ± 1.67 0.039 
K+ (mmol/L) 15 3.81 ± 0.47 4.11 ± 0.43 0.151 
iCa2+ (mg/dL) 15 1.02 ± 0.11 1.04 ± 0.13 0.657 
Glu (mg/dL) 15 259.86 ± 31.99 360.00 ± 34.04 0.014 
Hct (% PCV) 15 41.84 ± 2.48 42.86 ± 3.19 0.522 
Hbg (g/dL) 15 13.99 ± 0.83 13.90 ± 1.10 0.589 
Data are presented as mean ± standard deviations. Blood gas and electrolyte parameters: 
pCO2: Partial pressure of carbon dioxide (mmHg); pO2: partial pressure of oxygen 
(mmHg); HCO3-: bicarbonate (mmol/L); BD: base deficit (mmol/L); BE: base excess 
(mmol/L); sO2: oxygen saturation (%); Na+: sodium (mmol/L); K+: potassium 
(mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose (mg/dL); Hct: hematocrit (% 
PCV); and Hbg: hemoglobin (g/dL).
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Supplemental Table 3.1: Baseline acid/base and electrolyte values for combined 
males and females groups. 
  Survived 
N=16 
 Died Prior to 72 
hours 











Mean ± SD 
 
P-value 
pH 16 7.30 ±  0.04 15 7.31 ±  0.05 0.525 
pCO2 
(mmHg) 
16 60.11 ±  6.29 15 58.54 ± 4.80 0.537 
pO2 (mmHg) 16 125.33 ± 13.87 15 121.29 ± 14.41 0.412 
Beecf 
(mmol/L) 
16 3.33 ±  0.49 15 3.50 ± 0.52 0.673 
HCO3- 
(mmol/L) 
16 29.95 ± 1.59 15 29.50 ± 2.24 0.883 
Na+ (mmol/L) 16 137.60 ± 1.51 15 137.19 ± 1.60 0.792 
K+ (mmol/L) 16 3.73 ± 0.34 15 3.81 ± 0.47 0.463 
iCa2+ (mg/dL) 16 1.01 ± 0.16 15 1.02 ± 0.11 0.633 
Glu (mg/dL) 16 223.67 ± 22.67 15 259.86 ± 31.99 0.179 
Hct (% PCV) 16 40.13 ± 2.13 15 41.84 ± 2.48 0.347 
Hbg (g/dL) 16 13.65 ± 0.76 15 13.99 ± 0.83 0.266 
Data are presented as mean ± standard deviations. Blood gas and electrolyte parameters: 
pCO2: Partial pressure of carbon dioxide (mmHg); pO2: partial pressure of oxygen 
(mmHg); HCO3-: bicarbonate (mmol/L); BD: base deficit (mmol/L); BE: base excess 
(mmol/L); sO2: oxygen saturation (%); Na+: sodium (mmol/L); K+: potassium 
(mmol/L); iCa2+: ionized calcium (mmol/L); Glu: glucose (mg/dL); Hct: hematocrit (% 
PCV); and Hbg: hemoglobin (g/dL). 
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Table 3.5: Predictors of infarct volume in aged rats (n = 15) 
Variable  β P-value 
DpH (pre- to post-MCAO) 0.667 0.031 
DpH (post- to 72 hours-MCAO -0.683 0.034 




Table 3.6: Predictors of edema volume in aged rats (n = 16) 
Variable  β P-value 
DNa+ (post- to 72 hours-MCAO) -1.355 0.011 
DiCa2+ (post- to 72 hours-MCAO) -0.973 0.018 




Figure 3.1 Permanent Timeline: The first venous blood sample collection (represented by 
1st iSTAT) to MCAO takes approximately 30 minutes (represented by the shaded box). 
The post-MCAO sample was taken approximately seven minutes after induction of the 
MCAO (represented by 2nd iSTAT). The MRI scans and 3rd iSTAT collection were 





Figure 3.2.A-D MRI Images of Infarct and Edema Volumes 
 
 
3.2a: Representative permanent-MCAO Diffusion Tensor Imaging (DTI) image of infarct 
volume. 3.2b: Representative permanent-MCAO T2-weighted image of edema volume. 
3.2c: DTI imaging revealed the volume of brain parenchyma demonstrating restricted 
diffusion of infarct volume visibly affected after pMCAO. Shading indicates the 
calculation made by manual segmentation. 3.2d: T2 weighted imaging revealed the 
volume of brain parenchyma demonstrating restricted diffusion of edema volume visibly 
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CHAPTER 4. EVALUATION OF SEX DIFFERENCES IN ACID/BASE AND ELECTROLYTE 
CONCENTRATIONS IN ACUTE LARGE VESSEL STROKE 
Abstract 
Introduction and Purpose: We have developed a protocol to collect and evaluate arterial 
blood immediately distal and proximal from the removed intracranial thrombus during 
mechanical thrombectomy. These samples provide a unique resource in evaluating acute 
changes in acid/base and electrolyte concentrations at the time of ischemic stroke. The 
purpose of this study was to compare acid/base and electrolytes obtained proximal and 
distal to the occluded intracranial thrombi between male and female acute ischemic 
stroke participants at the time of thrombectomy; and to determine whether arterial blood 
gas values predict outcomes in male and female participants. 
Methods: We analyzed the first 49 subjects (age = 67 ± 15.0, 21 males) in the BACTRAC 
registry. We compared arterial blood gas of blood distal versus proximal to the thrombus 
during thrombectomy which provided acid/base levels (pH, pCO2, pO2, BD, HCO3-) and 
electrolyte values (iCa2+, K+, and Na+). Comparisons were evaluated by one-way 
repeated measures ANOVA (p < 0.05. Moderated multiple regression with an interaction 
term of sex determined predictors of infarct volume, edema volume, and infarct time. 
Results: Our participants revealed compensated metabolic acidosis with an elevated 
oxygen concentration in both blood samples. Analysis indicated several significant 
differences in the proximal blood samples between sex (pH, pCO2, and K+). Bicarbonate 
and base deficit were predictors of infarct time in only female participants.  
Discussion and Conclusion: Acid/base and electrolyte response to ischemic conditions 
differ between men and women and these early changes could be used to predict stroke 
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outcomes in a sex-dependent manner. These findings provide a novel insight into the 




Ischemic stroke is the leading cause of disability in the United States and affects 
over 800,000 Americans per year [1]. Approximately 87% of strokes are ischemic, 
resulting from an obstruction of blood flow to the brain [1]. When a cerebral thrombus 
blocks an artery, tissue damage transpires within a few hours of ischemic stroke onset 
due to neuronal cell death but with treatment the dying neurons in the penumbra may be 
salvaged [2, 3]. Acute ischemic stroke triggers an ischemic cascade which causes injury 
to cerebral tissue; this cascade may persist for many days post stroke. The 
pathophysiological processes following ischemic stroke are complex, involving acidosis, 
energy failure, increased intracellular calcium, excitotoxicity, activation of neuronal and 
glial cells, free radical production, and disruption of the blood-brain barrier (BBB) [4, 5]. 
Because time is crucial, treatments have focused on removing the thrombus as quickly as 
possible. 
The current standard treatment of acute ischemic stroke focuses on recanalization 
of the occluded intracranial vessel. Current therapies aim to dissolve or remove the 
thrombus; this includes the use of tissue plasminogen activator (tPA) and mechanical 
thrombectomy [6-8]. tPA is a serine enzyme that catalyzes the conversion of plasminogen 
to plasmin, which is the primary mechanism for thrombolysis and mechanical 
thrombectomy is a procedure to remove a thrombus and re-establish blood flow for 
emergent large vessel occlusions (ELVO) [9, 10]. Unfortunately, patients must meet 
specific criteria to receive either or both of these treatments, and the treatments must be 
administered within the first few hours from stroke onset to achieve optimal efficacy for 
better functional outcomes [9-13]. Rates of arterial recanalization are higher due to the 
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use of tPA and mechanical thrombectomy, yet their effect on patient long-term functional 
outcomes remains inconclusive [14-16]. It is also unclear whether outcomes after stroke 
treatment for ELVO differ by sex. 
A principal variable that may be affecting stroke outcomes is the biological sex of 
the patient. Ischemic stroke is the fifth leading cause of death for men in the US, but third 
leading cause of death for women, occuring in about 55,000 more women than men each 
year [1]. Women age 45-65 years old are at a higher risk (20%) of having a recurring 
stroke compared to their male counterparts (10%) [1]. Clinical studies have demonstrated 
the existance of sex-specific effects of stroke therapies. In a failed clinical trial, uric acid 
was found as an effective treatment in women, but not men [17]. This finding initially 
went unnoticed and was detected only after the results were reanalyzed according to sex 
differences [17]. As such, there is a need to further explore the relationship of sex 
differences and stroke outcome by an evaluation of males and females 
neurophysiological changes after stroke.  
While mechanical thrombectomy and tPA have both become standards of care, 
mechanical thrombectomy provides a rare opportunity to examine neurophysiological 
changes occurring during stroke. In the setting of mechanical thrombectomy for emergent 
large vessel occlusion (ELVO), we have developed a protocol to collect and evaluate 
blood immediately distal and proximal from the removed intracranial thrombus [18]. We 
can analyze these tissues to better understand their neurochemical properties and assist in 
the development of adjunctive therapies to compliment current stroke treatments, 
particularly whether those treatments need to be specially tailored to men or women. 
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Our previous two studies reported changes in venous acid/base and electrolyte 
concentrations within a few minutes of focal ischemia in young male rats, in addition to 
aged male and female rats, and these changes predicted infarct and edema volumes and 
mortality [19]. Our findings in animal models of stroke suggested that changes in early 
blood chemistry might be used to predict stroke outcomes. Thus, the purpose of this study 
was to evaluate the acid/base and electrolytes in distal and proximal blood to the 
occluded intracranial thrombi between male and female acute ischemic stroke 
participants at the time of thrombectomy; and to determine whether these acid base and 
electrolyte values predict stroke outcomes (infarct and edema volume and/or infarct time) 
dependent on sex. 
Methods 
Study Design 
We developed the Blood and Clot Thrombectomy Registry and Collaboration 
(BACTRAC) protocol: an Institiutional Review Board approved tissue banking strategy 
for emergent large vessel occlusion (clinicaltrials.gov NCT03153683) [18]. The 
BACTRAC study is a non-probability, convenience sample of participants (³ 18 year 
olds) treated with mechanical thrombectomy for ELVO ischemic stroke at a large 
academic comprehensive stroke center in Lexington, Kentucky between May 2017 
through December 2018. Institiutional Review Board approval was obtained, and all 
participants or legal authorized representative provided informed consent.  
A sample size of 45 was determined by a power analysis calculation based on 
planned analyses for independent t-tests, one-way repeated measures analysis of variance 
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(RM-ANOVA), and moderated multiple regression. Independent t-tests were calculated 
using a level of 0.05, and power of 0.80, and a medium effect size. RM-ANOVA were 
calculated using a level of 0.05, and power of 0.80, and a large effect size. For moderated 
multiple regression, sample size were calculated with a level of 0.05, power of 0.80, a 
large effect size, and appropriate number of predictors. 
Sample Population 
Participants age 18 and over who were hospitalized with a diagnosis of an 
ischemic stroke who underwent thrombectomy were screened for study eligibility. 
Participants were candidates for inclusion if they meet criteria: a) signed and dated 
informed consent (within 24 hours of thrombectomy completion time), b) adult males and 
females of all races/ethnicities, c) acute ischemic stroke based on clinical and 
radiographic evidence as determined by stroke neurology team, d) for intra-arterial 
thrombectomy as determined by neurointerventional radiologist attending physican, e) 
have an acute thromboembolus within an intracranial artery in a large cerebral artery (i.e 
internal carotid, anterior cerebral, middle cerebral) or posterior circulation 
(vertebral/basilar), f) participants with impaired capacity may be included, since the 
ischemic stroke might be the cause of their incapacity, and g) to undergo endovascular 
thrombectomy. Participants were excluded if a) they were pregnant or breastfeeding, b) 
had disability from a prior stroke due to the inability to control for preexisting 
neurological impairment, and c) were participating in other studies receiving treatment 





On admission to the study, demographic data were collected from the 
participant’s medical record. Baseline medical history and comorbidity conditions, 
concomittant medications, vital signs, National Institutes of Health Stroke Scale 
(NIHSS), computerized tomography (CT) scan to verify large vessel occlusion stroke and 
thrombectomy eligibility, and time of last known normal (LKN) symptoms (prior to 
ischemic stroke) were identified. 
Once a participant was determined by neurointerventional radiologist (NIR) for 
thrombectomy they were then enrolled into the study. During the thrombectomy 
procedure, the NIR obtained approximately 1ml of whole arterial blood from the 
microcatheter distal to the cerebral thrombus, prior to thrombectomy and approximately 
7ml of whole arterial peripheral blood from the internal carotid artery. This was a 
coordinated effort between the on-call research staff, attending NIR, and procedural nurse 
for the participant. From the distal and peripheral blood samples collected, 500 µL (0.5 
ml) of peripheral blood and distal blood were sent to the hospital’s central laboratory for 
blood gas (pH, partial pressure carbon dioxide, partial pressure oxygen, base deficit, and 
bicarbonate) and electrolyte values (ionized calcium, potassium, and sodium) separately 
through aliquots placed into standard hospital blood gas kits. The remaining blood was 
initially processed and stored in -80 freezer for future analyses. Within 24 hours post-
thrombectomy, LKN to thrombectomy completion time (infarct time), thrombolysis in 
cerebral infarction (TICI) score, magnetic resonance imaging (MRI) and/or computed 
tomography (CT) scan was performed and radiographic endpoints were collected: infarct 
and edema volumes, hemorrhagic grade, and CTA collateral score. A final NIHSS was 
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performed at discharge. These data were entered into the study institution’s stroke 
registry that is maintained using REDCap software.  
Data Analysis 
Descriptive statistics were used to characterize the participants by male and 
female. Participant demographics and baseline characteristics were assessed with 
independent t-tests for continous variables and Chi-square tests of associations based on 
categorical (ordinal and binary) variables to assess for sex differences. Comparisons of 
acid/base and electrolyte concentrations from distal to peripheral blood between the sexes 
were evaluated by one-way repeated measures ANOVA. A moderated multiple 
regression with interaction term of sex was used to determine predictors of stroke 
outcomes (infarct and edema volumes, and/or infarct time). An interaction term was 
created with acid/base and electrolyte variables x sex and were entered into the regression 
model in two steps with backward entry. Dummy variable of sex was coded as male = 0, 
female = 1. Age was entered into block 1 as a control variable, the functional outcome 
variables (infarct volume, edema volume, and infarct time) were dependent variables, 
while mean changes in acid/base parameters x sex were entered into block 2. The 
adjusted R2 determined the variance explained in the functional outcomes by each 
variable. Multicollinearity was assessed in each regression and P-to-P plot was used to 
assess the changes in acid/base and electrolyte concentration data for normal distribution. 
Data from ischemic stroke participants were analyzed using SPSS, version 24 software 






 Forty-nine participants were treated with mechanical thrombectomy during the 
study period. Our participants were primarily female (57%), Caucasians (84%), and aged 
67 ± 15 (Table 1). Sample participant characteristics and comparison based on gender are 
presented in Table 1. There were similarities in BMI, smoking status, NIHSS on 
admission and discharge, recanalization rate of TICI scores, infarct and edema volumes, 
and hemorrhagic grade between the sexes. The majority of comorbidities were similar 
between the sexes, however more females (42.9%) than males (9.5%) were diabetic (p = 
0.004). More males (47.6%) than females (17.9%) displayed absent collaterals on 
presentation, over 50% of an M2 territory (p = 0.027), while more females (57.1%) than 
males (42.9%) presented with diminished collaterals, over 50% of M2 territory. The 
mean infarct time based on symptom onset to thrombectomy completion time 
demonstrated over a two hour difference between females (8 hours and 53 minutes) 
compared to males (6 hours and 35 minutes; p = 0.081). 
Arterial Blood Gas Differences Between Male and Female Participants 
 Results from the one-way repeated measures analysis of variance (RM-ANOVA) 
of blood gas parameters of the sexes from distal and proximal arterial blood at the time of 
thrombectomy are presented in Table 2. There were sex differences in pH (male 7.34 ±  
0.04 vs female 7.39 ±  0.06, p = 0.046), partial pressure carbon dioxide (male 39.60 ±  
4.22 vs female 36.40 ±  3.87, p = 0.002), and potassium (male 3.66 ± 0.42 vs female 3.31 
± 0.46, p = 0.004) in proximal samples. The other measured blood gas and electrolyte 
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concentrations did not show significant differences between the sexes. Mauchly’s test 
indicated that the assumption of sphericity had been met since it is based on two levels 
(distal and proximal). There were significant interaction effects between two of the distal 
and proximal samples based on sex (partial pressure carbon dioxide: df = 1, F = 8.87, p = 
0.005; and potassium: df = 1, F = 1.816, p = 0.009).  
Predictors of Stroke Outcomes 
 To examine the possibility that sex was a moderator, an interaction term of sex 
was created for acid/base and electrolyte concentrations. Moderated multiple regression 
analyses (n = 49) were nonsignificant in the changes of acid/base and electrolyte 
parameters to infarct volume and edema volume (p > 0.05) (Tables 4.3 and 4.4). An 
additional moderated multiple regression analyses (n = 49) with interaction term of sex 
demonstrated the changes in base deficit (BD) and bicarbonate (HCO3-) from distal to 
proximal arterial blood samples were predictors of infarct time (F (4, 27) = 3.023, p = 
0.042) after controlling for age. This indicates a positive coefficient between BD and 
HCO3- together with the extent of infarct time, as changes in BD and HCO3-  increased, 
infarct time increased. These variables explained 12% of the total variance in the model, 
as predictors of infarct time (Table 4.5). 
Discussion 
Overall, our results revealed there was relationship between base deficit, 
bicarbonate, and infarct time, in women but not men. Women had increased infarct time 
compared to men and on average and had a higher volume of collaterals on presentation 
to the hospital (57.1% to 42.9%). Additionally, we expected to see acidosis and hypoxia 
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in the distal blood due to the blockage of the artery from the cerebral thrombus. This 
study shows that regardless of sex differences there was a compensated metabolic 
acidosis with an elevated oxygen concentration in our ischemic stroke participants at the 
time of thrombectomy. 
We determined that as changes in base deficit and bicarbonate increased, infarct 
time increased, but only in female participants. On average our female participants had a 
two and half hour increase in time from their last known normal symptom to 
thrombectomy completion time compared to male participants. We are unsure why 
women’s treatment time varied from men’s treatment time, but we might speculate from 
existing research that this is due to the different social experience of men and women. 
Women experience pre-stroke social isolation and lack of support, which has been found 
to contribute to poorer functional outcomes after stroke due to poor compliance, 
depression, and stress compared to men [21]. Framingham Heart Study found women 
more at risk for stroke incidence, lifetime risk of stroke, age at first stroke, post-stroke 
disability, and institutionalization rates [22]. Therefore, a delay in treatment for women 
could increase the damage from an ischemic stroke and decrease their chances of 
receiving treatments, such as tPA. In an experimental model of stroke, we found venous 
blood bicarbonate in aged rats to be a predictor for mortality with no sex differences [23]. 
However, a larger sample size is needed for the variability seen in the ischemic stroke 
population to uncover associations, such as mortality or other poorer stroke outcomes, 
especially if sex dependent. 
Other sex differences were detected in proximal blood in pH, partial pressure 
carbon dioxide (pCO2), and potassium (K+). These findings demonstrate differences in 
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the early response in blood to stroke between men and women. A larger sample would 
give us insights into whether these factors could be used as determinants of prognostic 
factors for stroke outcomes which may differ between men and women. 
To our knowledge, only one other report exists that evaluated distal and proximal 
arterial blood samples adjacent to the cerebral thrombus, Flores et al. (2011) found 
significant differences in partial pressure oxygen and oxygen saturation from ischemic 
stroke patients (n = 16) [24]. Their study was a smaller pilot study of acid/base and 
electrolyte concentrations at time of thrombectomy and results were not categorized by 
sex. Our results demonstrated similar values in both blood samples for pH, Na+ and iCa2+, 
in addition to proximal pCO2. However, we found an elevated concentration of oxygen 
and lower concentrations in both blood samples for HCO3- and K+, and distal pCO2 in our 
results. These differences between the studies could be due to a variety of reasons, such 
as thrombectomy technique, handling of samples or patient population. More studies 
examining blood collected during thrombectomy will enable answering the causes of the 
descrepancies between these first two studies. 
Overall, we expected the distal blood to reveal acidosis and hypoxia due to the 
blockage of the artery by the cerebral thrombus, however, we did not see those changes 
in our results. This may be due to the participant’s cerebrovascular system, collaterals, or 
the vessel is not fully occluded by the thrombus. More female than males had collaterals 
on presentation to the hospital. A limitation to the study is we did not collect a 
comparison CTA collateral score post-thrombectomy to determine the amount of 
perfusion the brain regained. Researchers recently evaluated collaterals based on sex in 
young, aged, obese, and hypertensive male and female mice [25]. Female mice 
67 
 
demonstrated smaller infarcts compared to male mice but was not associated with having 
greater extent of collaterals or remodeling [25]. An increase in sample size and collection 
of long-term imaging will permit a better understanding of the relationship between 
collaterals and blood gases during stroke. 
Our blood gas results display compensated metabolic acidosis with pH within 
normal range, decreased values for pCO2, HCO3-, and base deficit [26, 27]. The majority 
of our participants were mechanically ventilated or received supplemental oxygen 
throughout the thrombectomy procedure, which is a possible reason for the elevated 
oxygen concentration in both the distal and proximal blood samples. Another possibility 
is over half of our participants having at least 50% of collaterals on presentation to the 
hospital. This increase of intraluminal partial pressure oxygen concentration did not 
correlate to a clinical improvement in our participant population showing that other 
factors could be accounting for maintenance in acid/base balance. 
Hypokalemia and hypocalcemia were seen in both blood samples from our 
population. Hypokalemia may be caused by hyperventilation, which often occurs under 
anesthesia on a ventilator during mechanical thrombectomy [28]. Another explanation 
may be excessive urine loss, prolonged diarrhea, or vomiting, which are commonly seen 
in critically ill patients [29]. Hypocalcemia may result from the dilution of plasma seen in 
administration of fluid during resuscitative efforts in the ICU [30], in addition to 
increased mortality rate in ICU patients [31]. Lower venous total serum calcium 
concentrations were associated with more severe clinical symptoms following stroke 
onset, worse functional outcomes, and hemorrhagic transformation post-thrombectomy in 
ischemic stroke patients [32-34]. Higher venous total serum calcium levels detected 
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within 24 hours of stroke onset were associated with better functional outcomes and 
reduced cerebral infarcts in acute ischemic patients [35-37].  
Limitations 
 There are several limitations to this study. The sample for this study was small 
and mostly Caucasian. This was a non-probability sample based on completed 
mechanical thrombectomy procedures. The standard of care includes baseline imaging of 
CT and/or MRI upon presentation to the hospital. Based on this imaging, the 
neuroradiologist calculates infarct and edema volumes, CTA collateral scores, and 
hemorrhagic grade scores. Follow-up imaging is needed to understand how 
thrombectomy relates to participant stroke and functional outcomes. 
Conclusion 
 This study is among the first to examine early changes in blood chemistry of acute 
ischemic stroke participants who underwent mechanical thrombectomy. As demonstrated 
by previous reports, we found differences in the physiological response to stroke between 
men and women, which suggests therapeutic approaches may want to take into 
consideration sex. Thrombectomy is now a standard of care for ischemic stroke and our 
study population is growing. With an increased sample size, more associations could be 
elucidated not only based on sex but also co-morbidities and other patient factors relating 
to the patient population. 
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Table 4.1: Baseline Demographics and Characteristics for Ischemic Stroke Participants. 
 Males (n = 21) Females (n = 28) p value 
Age (Years) 67 + 16.54 67 + 14.11 0.961 
Ethnicity  
   African-American 
   Caucasian 
   Unknown 
 
1 (4.8)  
20 (95.2) 
0 (0.0)  
 
2 (7.1)  
22 (78.6) 






   Under/Normal Weight 
   Overweight 
   Obese 
   Morbidly Obese 
 
7 (33.3)  




11 (39.3)  









   Hypertension 
   Atrial Fibrillation 
   Diabetes 
   Hyperlipidemia 
   Previous Stroke 
   COPD 


























   Never 
   Currently 













NIHSS on Admission 
   Minor Stroke (1-4) 
   Moderate Stroke (5-15) 
   Moderate/Severe (16-20) 
   Severe Stroke (≥ 21) 















NIHSS at Discharge 
   Minor Stroke (1-4) 
   Moderate Stroke (5-15) 
   Moderate/Severe (16-20) 
   Severe Stroke (≥ 21) 


















Table 4.1 (continued). 
TICI Score 
2A = < 50% Perfusion    
2B = > 50% Perfusion 

















395.29 + 285.12 
 
533.07 + 254.68 
 
0.081 
Infarct Volume (cm3) 81.43 + 97.27 66.30 + 94.07 0.632 
Edema Volume (cm3) 70.68 + 97.4 64.71 + 86.34 0.822 
Hemorrhagic Grade 
    None 
    HI1 
    H12 
    PH1 



















CTA Collateral Score 
   0 
   1 
   2 
















Values are mean ± SD or (%). Comparisons were performed with independent t-tests, 
Chi-square tests based on  distribution of data.
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Mean ± SD 
Male (n = 21) 
Mean ± SD 
Female (n = 28) 









7.36 ±  0.06 7.35 ± 0.05 7.38 ± 0.05 0.152 






32.21 ±  5.11 34.70 ± 4.92 30.34 ± 4.96 0.059 






213.98 ± 59.51 209.86 ± 64.12 217.07 ± 56.80 0.779 






-6.28 ±  2.68 -5.83 ± 2.27 -6.65 ± 2.07 0.560 






19.17 ± 2.41 19.38 ± 2.18 19.02 ± 5.66 0.508 






140.47 ± 4.66 140.19 ± 4.09 140.68 ± 4.11 0.748 






3.04 ± 0.86 3.24 ± 0.82 2.88 ± 0.87 0.116 










3.86 ± 0.79 3.94 ± 0.75 3.81 ± 0.83 0.552 
4.33 ± 0.22 4.32 ± 0.25 4.34 ± 0.20 0.994 
Data are presented as mean ± standard deviations. pCO2: Partial pressure of carbon 
dioxide (mmHg); pO2: partial pressure of oxygen (mmHg); HCO3-: bicarbonate 
(mmol/L); BD: base deficit (mmol/L); BE: base excess (mmol/L); sO2: oxygen saturation 





Table 4.3: Moderated Multiple Regression Variables Predicting Infarct Volume (n = 49) 
Variable B SE B β P value 
Age -1.56 1.22 -0.245 0.213 
DK+ x sex -78.86 74.20 -0.491 0.296 
DBD x sex -14.30 12.30 -0.537 0.254 
Abbreviations: K+: potassium (mmol/L); and BD: base deficit (mmol/L).  




Table 4.4: Moderated Multiple Regression Variables Predicting Edema Volume (n = 49) 
Variable B SE B β P value 
Age -1.18 1.31 -0.177 0.377 
DK+ x sex -83.33 77.49 -0.502 0.291 
DBD x sex -16.11 12.87 -0.584 0.220 
Abbreviations: K+: potassium (mmol/L); and BD: base deficit (mmol/L). 




Table 4.5: Moderated Multiple Regression Variables Predicting Infarct Time (n = 49) 
Variable B SE B β P value 
Age 0.65 2.69 0.38 0.037 
DHCO3- x sex 37.81 18.15 0.55 0.019 
DBD x sex 37.50 15.40 0.47 0.044 
R2 = 0.18, adjusted R2 = 0.12, df = 4, F = 3.023, Durbin-Watson = 1.918 





















Copyright © Sarah R. Martha 2019 
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CHAPTER 5. DISCUSSION AND CONCLUSIONS 
Background and Purpose 
Given that ischemic stroke is the leading cause of disability in the United States, 
the need to refine and develop innovative treatments remains a pressing priority for 
medical researchers. Nurse researchers can contribute to these efforts by bridging the gap 
between clinical and bench science, and harnessing their knowledge of patient 
experiences to assist in the creation of multi-disciplinary studies. This dissertation 
emerges from such a collaboration and contributes to the effort to expand the field of 
nursing research interest in neuropathology and quantitative research. 
The purpose of this dissertation was to examine neurochemical factors associated 
with the initial pathophysiological reaction to acute large vessel occlusion in rodent 
models and individuals diagnosed with ischemic stroke. Three studies were conducted 
focused on acid/base and electrolyte concentrations in these populations: 1) a descriptive 
correlational analysis of the associations between venous blood gases, infarct volume and 
mortality in young male (three month old) Sprague Dawley rats; 2) a descriptive 
correlational analysis of the relationship between venous blood gases to infarct and 
edema volumes, and mortality in aged (18 months old) male and female Sprague Dawley 
rats; 3) a descriptive correlational study comparing acid/base and electrolyte 
concentrations in patients diagnosed with ischemic stroke who underwent mechanical 
thrombectomy.  
This chapter will present a summary of the findings from the three manuscipts. I 
will then synthesize those findings to explain how the results help further our 
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understanding of the neurochemical changes that take place during stroke. 
Recomendations for future research will be addressed, as will limitations both of the 
current study and existing efforts to study ischemic stroke.  
Summary of Findings 
In Chapter Two, we examined the differences between acid/base balance and 
electrolyte concentrations in two focal ischemia models in young male rats. This was a 
descriptive correlational study evaluating three-month old Sprague-Dawley male rats that 
underwent permanent (n = 18) or transient (n = 19) middle cerebral artery occlusion 
(MCAO). Pre- and post-MCAO venous blood samples from permanent and transient 
models provided pH, carbon dioxide (CO2), oxygen (O2) , bicarbonate (HCO3-), glucose, 
hemoglobin, hematocrit, and electrolyte values of ionized calcium (iCa2+), potassium 
(K+) and sodium (Na+). Mean differences were seen in the blood gas and electrolyte 
concentrations between pre- to post-MCAO in both models. pH and iCa2+ were 
predictors of infarct volume in the permanent MCAO model. The transient MCAO model 
exhibited greater survival to 72 hours compared to the permanent MCAO model (p = 
0.045). 
In Chapter Three, we compared acid/base balance and electrolyte concentrations 
at three time points between aged male and female rats. We examined venous blood gas 
samples of aged (18 month old) Sprague Dawley male (n = 15) and female (n = 16) rats 
1) pre-, 2) post-, and 3) at 72 hours of permanent MCAO. The repeated measures 
ANOVA revealed no mean differences in acid/base and electrolyte concentrations from 
the three time points between the sexes. However, changes in pH (from pre- to post-
MCAO and post-MCAO to 72 hours) and changes in Na+ and iCa2+ (from post-MCAO to 
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72 hours) were predictors of infarct volume and edema volume, respectively. There was a 
3.25 times increased risk for mortality in rats based on changes (cut-off range within -
2.00 to -7.00) in HCO3- levels (pre- to post-MCAO). 
In Chapter Four, we compared acid/base balance and electrolyte concentrations in 
arterial distal and proximal blood to the cerebral thrombus between male (n = 21) and 
female (n = 28) ischemic stroke participants who underwent mechanical thrombectomy. 
On average female participants had a two and half hour increase in time from ischemic 
stroke symptom onset to vessel recanalization or infarct time compared to male 
counterparts. Changes in HCO3- and base deficit were found to be predictors of infarct 
time, but only in females.  
Implication of Findings  
The results from this dissertation have expanded our understanding of 
neurochemical factors and neuropathology at the time of focal ischemia in rats and 
patients with ischemic stroke at the time of mechanical thrombectomy in a number of 
ways:  
1) In examining two different rodent models (permanent MCAO and transient 
MCAO), we were able to compare baseline blood gas values to blood gas values taken 
immediately after the occlusion. First, because the majority of stroke patients do not 
receive tPA and/or mechanical thrombectomy, this comparison in the permanent MCAO 
model is important because it reveals insights about the speed at which neurochemical 
changes take place. Second, the transient MCAO model resembles recanalization and 
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reperfusion of the artery and allows us to examine blood chemistry changes that occur in 
the brain after treatment. 
 2) In examining young male and aged male and female rats, we have identified 
predictors of infarct volume, edema volume, and mortality in an animal model. This 
insight is novel because there is no existing research of acid/base and electrolytes 
concentrations as predictors of stroke, let alone at this early phase of stroke onset. This 
gives us an insights about the speed at which neurochemical changes are taking place. 
This is something we can observe in rodent models but which could aid us in 
understanding what occurs in patients who have an ischemic stroke. 
 3) We are among only a few researchers to compare acid/base and electrolytes 
from blood distal and proximal to the cerebral thrombus in patients after ischemic stroke. 
The protocol developed for the Blood and Clot Thrombectomy Registry and 
Collaboration (BACTRAC) study uses an innovative method to obtain blood specimens 
and allows for a systematic understanding of ischemic stroke neuropathology at the time 
of mechanical thrombectomy. Our results challenge the current literature by 
demonstrating that a compensated metabolic acidosis with an elevated oxygen 
concentration appeared in the distal blood. Future studies should aim to identify the 
percentage of arterial occlusion that occurred in patients undergoing thrombectomy, 
ventilator settings during thrombectomy, and the amount of the time the patient was 
provided supplemental oxygen. In understanding and improving stroke outcomes, 
investigators should evaluate and compare arterial blood gases not only during 
thrombectomy but across several points during the patient’s hospital stay and the 
relationship to functional outcomes. 
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4) By examining sex differences in acid/base and electrolyte concentrations in 
patients, we discovered significant differences in the proximal blood in patients 
diagnosed with ischemic stroke. In females, we found that changes in bicarbonate and 
base deficit were predictors of infarct time. Additionally, in females, there was 
approximately 2.5 hour increase from symptom onset to thrombectomy completion time 
compared with males. In our study population, more males than females displayed absent 
collaterals on presentation to the hospital. Sex differences are generally ignored in 
clinical trials for stroke therapies and our results suggest a renewed importance in 
considering how differences in treatment times affect overall outcomes for female 
patients. Future studies should aim to identify different parameters to determine stroke 
outcomes based on sex. Investigators should focus on factors like distance and time from 
LKN to the hospital, marriage status, insurance status, imaging issues, and delay in 
hospital diagnosis. 
Limitations 
Emergent large vessel occlusion (ELVO) accounts for 20-40% of ischemic 
strokes and is the most disabling form of stroke [1-3]. Nevertheless, our understanding of 
stroke pathophysiology remains limited due to the challenges of studying stroke onset in 
humans. Animal models, particularly young rodents, have long served as a way for 
researchers to model stroke pathophysiology, yet stroke research has, on the whole, 
suffered an inability to provide clinically relevant animal-to-human translation. This is 
due in part to how animal studies are conducted, which typically follows a uniform 
practice of selecting young male rodents as its test subjects. The majority of ELVO stroke 
patients are middle-aged to elderly and are of both sexes, revealing that there is an age 
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and sex mismatch between ischemic stroke patients and animal models. Rethinking of the 
experimental animal models needs is required, especially in encouraging the use of aged 
male and female rats with comorbidities to more closely mirror human populations.  
A limitation for Chapters Two and Three is venous blood samples were not 
always obtained pre-, post-, and/or at 72 hours of MCAO procedure and therefore 
reduced the number of samples in analyses. We have identified several issues with the 
collection of blood samples, faulty iSTAT cartridges, air bubbles in blood, fragile 
vasculature of aged animals were fragile and IJ collapsed, and/or insufficient amount of 
blood drawn. Working with aged animals is challenging. Post-MCAO we had 
approximately 50% mortality rate decreasing our sample size, especially in aged female 
rats. We believe this is due to the aging vasculature of the animals. 
Another limitation with our human study is the nature and complexity of Blood 
and Clot Thrombectomy Registry and Collaboration (BACTRAC) study. BACTRAC is a 
multidisciplinary team operating in a clinical environment, and therefore, the potential 
data collection and specimen processing errors occurred. Additionally, the potential for 
sampling bias was present since the sampling strategy was purposeful, non-probability 
sample, and based on number of thrombectomy procedures completed. The current 
patient population used in this study is largely Caucasian and limited to the hospital’s 
location in Central Kentucky. A larger and more diverse sample size is needed. An 
additional limitation is that we could not control for all comorbidities present in our 
sample population of ischemic stroke participants.  
The BACTRAC study data are limited to the patient’s hospitalization, limiting our 
ability to study long-term impact on functional outcomes. The two blood samples 
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(proximal and distal) were drawn at approximately the same time during mechanical 
thrombectomy. Thus, it was not possible to compare across time points and longitudinal 
data is needed for a systematic understanding of changes. Additionally, imaging for the 
infarct and edema volumes were based on CT and/or MRI that was completed prior to 
thrombectomy. Based on this initial imaging, CTA scores and hemorrhagic grade scores 
were assigned. However, even though this is the standard of care, there is no long-term 
follow-up or re-evaluation to understand how the treatment relates to these outcomes.   
Recommendations for Future Research 
Future studies are needed to identify serum biomarkers to predict the risk of 
worsened long-term outcomes and/or increased risk for mortality. Mechanical 
thrombectomy provides a unique opportunity for researchers to further this work by 
expanding the collection and analysis of biospecimens (distal blood, proximal blood, and 
cerebral thrombus). To understand the complexity of stroke, researchers can analyze 
these tissues for different molecular targets (such as proteomics and genomics) that occur 
in response to ischemic stroke. Associations may be found between patient characteristics 
(based on comorbidities, age, and sex) and functional recovery. This information may aid 
in the reduction of symptom burden for individuals diagnosed with ischemic stroke. 
Investigators should also focus on data from ischemic stroke patients and attempt to 
discover target molecules and then in animals to establish mechanism, this will aid in the 
development of new stroke therapies, keeping in mind that sex differences may play a 
role in treatment success. Finally, researchers must begin to explore how patients’ 
respond to thrombectomy through long-term studies with ischemic stroke survivors and 
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